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Abstract
Alkylating agents such as sulfur mustard (S-Lost, mustard gas, SM, HD, bis(2-
chloroethyl)sulfide, Yperite), predominantly used by military forces, and related
chemotherapeutic drugs, e.g. chlorambucil (Cbl, trade name: Leukeran), are known
to cause severe cellular damage without being fully understood on a molecular level.
The discovery of sulfur mustard and its use as a chemical weapon was followed by the
detection of associated, medically useful toxicological properties, which paved the way
for the development of alkylating chemotherapeutics. Used since the beginning of the
20th century, SM has been deployed in several conflicts around the world. It can lead
to severe tissue damage - in particular dermal, mucosal, ocular and respiratory lesions
- followed by impaired wound healing. While investigations of the acute toxicity
have been the main focus up to now, explanations of long-term effects remain widely
obscure. Increased understanding of the molecular mechanisms involved might help
to identify new potential targets that could improve the general therapy of victims
and the development of specific therapeutics. The ability of SM to cause lasting
harm (e.g. cancer) and degenerative tissue damage after even a single exposure
might - among other pathological processes - be explained by the involvement of
underlying epigenetic modulations. The scientific field of epigenetics comprises
alterations and modifications in gene expression that are not structurally changing
the DNA sequence itself, but affecting chromatin organization as well as maintenance
by e.g. DNA methylation and modifying histone patterns. SM is mainly used as
a liquid or aerosolic chemical weapon agent (CWA) when dispersed, and directly
interacts with tissues it comes into contact with first. As well as the aforementioned
tissues, this interaction also involves corresponding small blood vessels. Blood vessel
malformation (e.g. cherry hemangioma) is a frequent observation after SM exposure.
Blood vessel formation depends on regeneration and immigration of endothelial cells.
Early endothelial cells (EEC), which are known to play an important role in the
formation of granulation tissue and the process of wound healing, provide a rational
in vitro model to analyze the molecular toxicology of SM. After determining the
lethal concentrations of sulfur mustard and assessing specific doses (0.5 µM, 1.0 µM)
at which EECs are affected but maintain their cell division and proliferation abilities,
we analyzed selected epigenetic modulators; a potential up- and downregulation of
epigenetically relevant genes was examined. The EECs were tested for histone di-
methylation (H3-K9, H3-K27, H3-K36), histone acetylation (H3-K9, H3-K27, H4-K8)
and global DNA methylation (5-mc, 5-hmc). The changes were investigated over
24 hours and for up to 4 cell passages. Moreover, we were able to assay abdominal-
thoracic skin samples from a laboratory worker who accidentally exposed himself to
a high dose of SM, which we received one year after the initial exposure subsequent
to a corrective surgical procedure. The results of our in vitro study clearly show
changing epigenetic patterns over time, which partly coincide with the findings from
the human skin samples exposed short-term to SM. Histone modifications generally
remained fewer and DNA methylation increased significantly. Future investigations
should focus on the confirmation of these results under in vivo conditions and include
possible therapeutic interventions, e.g. DNA methyltransferase inhibitors, to prevent
or reverse these effects.
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Zusammenfassung
Alkylierende Substanzen, wie das militärisch genutzte S-Lost (Senfgas, SM, HD, bis(2-
chloroethyl)sulfide, Yperite) und verwandte Chemotherapeutika, wie z.B. Chloram-
bucil (Cbl, Handelsname: Leukeran), sind bekannt dafür, schwere zelluläre Schäden
zu verursachen, wobei die zu Grunde liegenden molekularen Grundlagen noch zu
großen Teilen unverstanden sind. Der Entdeckung von S-Lost und dessen Einsatz als
chemischer Kampfstoff folgte die Feststellung verschiedener, medizinisch nützlicher
Eigenschaften, was den Weg für die Entwicklung alkylierender Chemotherapeutika
ebnete. SM wurde seit Beginn des 20. Jahrhunderts weltweit in verschiedenen Konflik-
ten verwendet. Sein Einsatz kann zu schweren Gewebeverletzungen mit nachfolgend
gestörter Wundheilung führen, die besonders dermale, mukosale, okuläre und respira-
torische Läsionen nach sich ziehen. Während bisher besonders Untersuchungen in
Hinblick auf die akute Toxizität im Fokus standen, mangelt es weiterhin an Erklärun-
gen für die auftretenden Langzeiteffekte. Ein genaueres Verständnis der beteiligten
Mechanismen könnte neue mögliche Angriffspunkte in Hinblick auf eine Verbesserung
der derzeitigen, allgemeinen Therapiemöglichkeiten aufzeigen und die Entwicklung
spezifischer Therapeutika ermöglichen. Die Fähigkeit von SM schwerwiegende Folge-
erkrankungen (z.B. Malignome) und degenerative Gewebeschäden nach bereits einer
einzigen Exposition zu verursachen, könnte unter anderem durch in Zusammenhang
stehende epigenetische Prozesse zu erklären sein. Das Wissenschaftsfeld der Epigene-
tik umfasst Veränderungen und Modifikationen in der Genexpression, die nicht die
Basenabfolge der DNA selbst, sondern die Organisation und molekulare Integrität
des Chromatins betreffen, z.B. in Form von DNA-Methylierung sowie der Modifi-
zierung von Histonmustern. SM ist ein hauptsächlich in flüssiger beziehungsweise
aerosolischer Form vorliegender, chemischer Kampfstoff und interagiert unmittelbar
mit Geweben mit denen es primär in Kontakt kommt. Dies beinhaltet, neben den
zuvor erwähnten, auch korrespondierende kleine Blutgefäße. Blutgefäßfehlbildungen
(z.B. tardive Hämangiome) werden häufig nach SM-Exposition beobachtet. Blutge-
fäßneubildung hängt von Regeneration und Immigration von endothelialen Zellen ab.
Frühe endotheliale Zellen, die bekannterweise eine wichtige Rolle in der Neubildung
von Granulationsgewebe und dem Prozess der Wundheilung besitzen, liefern ein
rationales in vitro Modell für die Analyse der molekularen Toxizität von SM. Wir
bestimmten zunächst die letalen Konzentrationen für S-Lost und die genauen Dosis-
bereiche (0,5 µM, 1,0 µM) in denen die EEC´s zwar Schaden davontrugen, aber die
Fähigkeit zur Zellteilung und Proliferation erhalten blieb, wonach epigenetische Mo-
dulatoren analysiert wurden. Wir untersuchten mögliche Up- und Downregulationen
epigenetisch-relevanter Gene. Die EEC´s wurden auf Histondimethylierung (H3-K9,
H3-K27, H3-K36), Histonacetylierung (H3-K9, H3-K27, H4-K8) und globale DNA-
Methylierung (5-mc, 5-hmc) getestet. Im Folgenden wurden Veränderungen über 24
Stunden und bis zu 4 Zellpassagen analysiert. Außerdem waren wir in der Lage eine
abdominell-thorakale Hautprobe von einem im Rahmen eines Arbeitsunfalls mit einer
hohen SM-Dosis exponierten Patienten mit in unsere Untersuchungen einzubeziehen,
die ungefähr ein Jahr nach Primärkontamination durch eine korrektive, chirurgische
Maßnahme gewonnen wurde. Die Ergebnisse unserer in vitro Studie zeigen deutlich
sich verändernde epigenetische Muster im Zeitverlauf je nach S-Lost Konzentration,
z.B. traten Histonmodifikationen seltener auf, wohingegen DNA-Methylierungen ins-
gesamt signifikant zunahmen. Dabei stimmen sie in weiten Teilen mit den Ergebnissen
der intoxikierten Hautprobe überein. Zukünftige wissenschaftliche Untersuchungen
sollten auf die Bestätigung der Ergebnisse unter in vivo-Konditionen abzielen und
mögliche therapeutische Ansätze, wie z.B. DNA-Methyltransferase-Inhibitoren, ein-
beziehen, um den beobachteten Effekten vorzubeugen oder sie zu behandeln.
III
List of Figures
1.1 Ocean dumping of containers with sulfur mustard. . . . . . . . . . . 2
1.2 Right forearm 11 days after accidental exposure to sulfur mustard. . 6
1.3 Abdominal region 10 days after accidental exposure to sulfur mustard. 7
1.4 Structural formula of sulfur mustard. . . . . . . . . . . . . . . . . . . 8
1.5 Structural formula of chlorambucil. . . . . . . . . . . . . . . . . . . . 8
1.6 Epigenetic mechanisms of gene regulation. . . . . . . . . . . . . . . . 9
1.7 Micrographs of Wright–Giemsa-stained endothelial cells. . . . . . . . 12
4.1 Exemplaric figure of cell nucleus analysis using immunofluorescence. 32
List of Tables
1.1 Sulfur mustard-induced clinical symptoms - most common effects on
often affected organs . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
IV
List of Publications
Original Research Articles Presented in this Thesis
Steinritz, D., Schmidt, A., Balszuweit, F., Thiermann, H., Simons, T., Striepling,
E., Bölck, B., Bloch, W. (2016). Epigenetic modulations in early endothelial cells
and DNA hypermethylation in human skin after sulfur mustard exposure. Toxicology
Letters, Vol. 244, pp. 95-102.
Simons, T., Steinritz, D., Bölck, B., Schmidt, A., Popp, T., Thiermann, H., Guder-
mann, T., Bloch, W., Kehe, K. (2018). Sulfur mustard-induced epigenetic modificati-
ons over time - a pilot study. Toxicology Letters, Vol. 293, pp. 45-50.
Further Publications
Steinritz, D., Schmidt, A., Simons, T., Ibrahim, M., Morquet, C., Balszuweit, F.,
Thiermann, H., Kehe, K., Bloch, W., Bölck, B. (2014). Chlorambucil (nitrogen mu-
stard) induced impairment of early vascular endothelial cell migration - Effects of
α-linolenic acid and N-acetylcysteine. Chemico-Biological Interactions, 219, 143-150.
Bloch, W., Simons, T., Steinritz, D., Schmidt, A., Bölck, B. (2014). Stability and
time course of epigenetic changes by S-/N-alkylating substances. Wehrmedizinische
Monatszeitschrift Vol. 58, pp. 316-317.
Bloch, W., Simons, T., Steinritz, D., Schmidt, A., Bölck, B. (2017). Sulfur mustard
and epigenetics. Wehrmedizinische Monatszeitschrift, Vol. 61, p. 9
V
1 Introduction 1
1 Introduction
1.1 History and Actuality
1.1.1 Sulfur Mustard - History
Alkylating agents have been subject of intense research since their discovery in the
19th century and frequent usage from the beginning of the 20th century onward [7,
19]. Yet there are many unsolved questions in relation to their severe toxicological
effects on different cell types [107, 114, 118]. The vesicant SM has by now a long
history as an excruciating military weapon. It incapacitates enemies rather than
killing them, and by the later development of nitrogen mustard-based derivates like
chlorambucil (Cbl, trade name: Leukeran) it found entrance into modern medicine
[19, 73, 93]. Cbl gained further importance in scientific research when used for
example as a mutagen for molecular mapping and structure-function correlations of
genomic regions [117]. SM was first synthesized by Despretz, supposedly in 1822,
followed by further characterization by Niemann and Guthrie in 1860 [82, 138]. The
German chemists LOmmel and STeinkopf shaped the well-known acronym LOST [82,
102]. Haber pushed the large-scale production of SM, which led to its initial military
usage - or more precisely to its first heavy application - during the First World War
(WWI) by German forces in Belgium in 1917, resulting in about 400,000 casualties
[82, 138]. Despite the international restriction of chemical warfare by the Geneva
Protocol in 1925, it was continuously produced and brought into action in various
conflicts around the world, among these the Rif War 1920-1927, Egypt against North
Yemen 1963-1967 and the Iran-Iraq War 1980-1988, whereupon it was specified in
the List of Schedule 1 substances within the Chemical Weapons Convention (CWC)
in 1993 as a substance with no other use than in warfare [18, 21, 43, 99]. In 1997 the
CWC agreement entered into force, mandating destruction of all chemical weapons
by 2007 [93]. But nearly 100 years after its first use, mustard gas - in some reports
referred to as “king of the battle gases” - is still a current threat in many parts of
the world [45, 69].
1.1.2 Sulfur Mustard - Actuality
During the Syria crisis, which started in 2012, large amounts of chemical warfare
agents, including SM, were confirmed as being part of the armory of the Syrian
military [128]. In private briefings to weapons experts in 2013, White House officials
said, analysts concluded, that Syria possessed about 300 metric tons of sulfur mustard
and unfortunately these weapons had probably been brought into action since the
conflict had started [45, 145]. In 2014 the allegedly last stockpiles of the chemical
armory were hydrolyzed on board the Cape Ray - a vessel equipped with mobile
chemical decontamination systems - in the Mediterranean Sea, and then shipped
to Finland, Britain, Germany and the US for final combustion of the hydrolysates
according to media reports of The Washington Post and The New York Times [46,
63, 13, 108]. Despite these attempts it is likely that SM was released in Avdiko,
Syria, causing at least 3 deaths and several casualties displaying the typical burning
signs of this agent [129]. In 2015 the BBC reported about an investigation from
the Organization for the Prohibition of Chemical Weapons (OPCW) which revealed
1 Introduction 2
that SM was most likely utilized in Marea, Syria during an attack in August of the
same year [14]. The news agency Reuters and the Security Council of the United
Nations (UN) reported about the evidence of the deployment of SM in Aleppo,
Syria in September 2016 based on laboratory analysis of blood samples obtained
from victims [95, 120]. As well as active deployment, another frequently forgotten
problem is still-undetected stockpiles that continue to pose a threat, as shown by the
non-occupational exposure of 43 people in Qiqihar, in Northeast China’s Heilongjiang
province, in 2003. When several barrels of SM leaked at a construction site that
was used by Japanese military forces and then abandoned in 1945, several different
kinds of typical injuries were reported [136]. Similar cases occurred in the area of
Bornholm, a Danish island in the Baltic Sea, where approximately 200,000 tons of
SM had been discarded and were sporadically and accidentally retrieved by local
fishermen, who then were exposed because of shell leakage [150]. Similar processes
of ocean dumping were registered in the Atlantic Ocean as depicted in Figure 1.1.
Figure 1.1: Ocean dumping of containers with sulfur mustard [68].
Although representing an oily liquid, SM was mistakenly called mustard "gas" in the
past due to its aerosolic condition when dispersed by explosion [75]. SM’s degradation
and reactivity depend heavily on its environment. In water, the process of hydrolysis
and dissolution of SM depends on the salt content, temperature, pH value, pressure,
density and viscosity [67]. The half-life in seawater at e.g. 5°C was stated to be
175min [36]. But it was proven that SM can resist degradation over longer periods
as well which enhances the risk of an eventual exposure [67]. Besides, SM and its
degradation products were found to be extremely stable in dry matrices for up to four
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years, so that an eventual exposure needs to be feared [98, 89]. Residues of SM were
found at autopsy even seven days after initial exposure in several tissues, particularly
in fat, skin with subcutaneous fatty tissue and in the brain [32]. The varying half-life
of SM in vivo has been observed in several studies [78, 12]. To avoid the aggregation
of SM, early decontamination of the affected environment and as part of the medical
approach remains highly important. A detailed operating plan regarding verification
of exposure, treatment options and approach to decontamination was for example
published by Steinritz et al. [135]. The limited half-life in vivo of pure SM and its
converted degradation products on the one hand, and delayed chronic health effects
on the other, pose questions about the molecular mechanisms, enacting long-term
modifications, that SM is capable of inducing [135].
1.1.3 Chlorambucil - Medical Use of Sulfur Mustard Derivates
Even though SM itself currently has no medicinal use, it has been serving as a
prototypic alkylating drug for research into the development of various medical
treatments. During the Second World War (WWII), a ship that carried mustard
gas shells exploded in Bari, Italy in 1943 [102]. Survivors were observed to develop
leucopenia after their rescue; this led to the idea of utilizing SM, specifically its
derivates, to treat diseases that induce a hyperplastic bone marrow and lymphocytosis
[56]. In the 1940s Goodman and Gilman had already begun clinical trials with nitrogen
mustard derivates for the treatment of lymphoma, and found them to be effective; this
resulted firstly in the development of aliphatic mustards like mechlorethamine and
then of less toxic aromatic nitrogen mustards like chlorambucil, which was approved
in 1957 [8, 34, 52]. Other chemically related chemotherapeutics with differing
toxicological properties like cyclophosphamid, ifosfamid, melphalan and bendamustin
were developed as well within a few years and are still of clinical relevance [137].
Cbl´s relatively slow reactivity and the possibility of its oral administration have
contributed since then to its distinct indications and wide usage [106]. As part of
the World Health Organization’s List of Essential Medicines it has been benefiting
patients with different diseases including leukemia, Hodgkin´s and non-Hodgkin´s
lymphoma, Morbus Waldenstrom, ovarian carcinoma, autoimmune and inflammatory
illnesses such as psoriasis, ulcerative keratitis or rheumatoid arthritis; in addition
to that, it helped to establish organ transplantation [2, 9, 98, 125, 140]. On the
other hand it is also known to act like a human mutagen, potentially causing other
neoplastic diseases [93]. Severe side effects include unwanted vascular tissue damage
and organ dysfunction [24].
1.2 Clinical Picture of Mustard Gas Intoxication and Side
Effects of Chlorambucil
1.2.1 Sulfur Mustard - Most Affected Organs
After contact with SM, vesicating lesions especially in dermal, mucosal, ocular and
respiratory tissues as well as systemic effects and, in the long-term, even psychological
symptoms were noticed, depending on the site, time course and concentration of the
exposure [115, 133]. Sulfur mustard-related injuries can take months to heal; cells
with high proliferative and metabolic capacity are particularly vulnerable [48, 98].
Most commonly affected are skin and eyes as well as the respiratory tract [69].
Normally starting a few hours after an exposure - with shorter latency at very high
doses and relative to the cell type - incapacitating effects begin to manifest with an
eventual death rate of less than 4%, but requiring elaborate medical intensive care
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Table 1.1: Sulfur mustard-induced clinical symptoms - most common effects on often
affected organs. Synopsis from [3, 11, 70, 35, 44, 48, 65, 75, 101, 104, 110,
111, 112, 147, 151].
dermal symptoms
acute
vesication/blistering, tautness, erythema/reddening, itching, edema
delayed
ulceration, epidermal necrosis, subepidermal location, disseminated bullae
long-term
wound healing disorders, pigmentation disorders, cancer development
ocular symptoms
acute
blepharospasm, burning, foreign body sensation, photophobia, lacrima-
tion, blindness
delayed
ulceration, scarring, corneal thinning, vasculitis of the cornea and con-
junctiva
long-term
aberrant vessel formation, neovascularization, chronic blepharitis, lipid
and cholesterol/amyloid deposition, limbal stem cell deficiency, perilimbal
conjunctival ischemia, blindness, mustard gas keratopathy
pulmonary symptoms
acute
cough, bronchial obstruction, dyspnoe
delayed
hyperreactive airways, bronchiectasis, pseudomembrane formation, em-
physema
long-term
interstitial fibrosis, bronchiolitis obliterans, decreased total lung capac-
ity, tracheobronchomalacia, air trapping, recurring chronic pulmonary
infections, mustard lung
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and specific burn management in order to prevent dehydration, electrolyte imbalance
and infection [18]. An important problem in terms of treatment is that patients
might barely complain about any symptoms in the first moments after contact so
that exposure can remain undetected leading to delays in diagnosis and therapeutic
measures. SM is systemically incorporated at a very low dose and was shown to
compromise multiple organ systems when less than 10% of the dermal body surface is
affected [75]. For skin cells the onset of symptoms can take from a few up to 24 hours
[135]. The feature of being very soluble in fat rather than in water makes human skin
and associated cell types like hair follicles and sweat glands particularly vulnerable.
While about 80% of SM evaporates after skin contact, the remaining 20% is absorbed
within approximately two minutes [70]. Symptoms may emerge as sunburn-like
erythema with tautness and reddening, which can escalate to ulceration, epidermal
necrosis together with subepidermal location, disseminated bullae and hypo- or
hyperpigmentation, notably in the intertriginous areas [112]. Development of skin
cancer as a long-term consequence was reported [110]. Ocular lesions are also common
with a varying frequency of up to 75-90% [11]. The unprotected eyes represent the
most sensitive organ showing a general latency of symptoms of about 1-4 hours [3, 135].
Keratitis and anterior uveitis as part of ocular symptoms can include the sensation
of dry eyes with foreign body sensation, photophobia and lacrimation [11, 48, 101].
Clinical findings comprise corneal thinning with irregularities, scarring, ulceration,
vasculitis of the cornea and conjunctiva [11, 48, 101]. Partially these effects heal
within 1-2 weeks, but in the long-term aberrant vessel formation, neovascularization
and chronic blepharitis, together with lipid and cholesterol/amyloid deposition, are
dreaded complications [3, 11]. Conjunctival ischemia and vasculitis caused by chronic
inflammation and pathological metabolic processes regarding corneal innervation
support the notion of SM’s chronic manifestation [11, 65]. In some patients, eye
damage undergoes a clinically silent phase before initiating a second cascade, leading
in the worst cases to organ malformation and blindness [65]. A comparative study
estimated the rate of pulmonary involvement at about 42.5%, where the most
common acute symptoms appeared to be cough and dyspnea [111]. Acute pulmonary
injury can lead via bronchial obstruction to respiratory failure with life-threatening
consequences like asphyxia [147]. Lung-specific cell types like type I and type II
alveolar epithelial cells show partial loss of cell membranes and disorganized microvilli
[151]. Macroscopically, tracheobronchomalacia and air trapping often appear in high-
resolution computerized tomography [104]. In the medium to long-term, victims can
suffer from hyperreactive airways, bronchiectasis, pseudomembranes, emphysema and
recurring chronic pulmonary infections resulting in a decreased total lung capacity
[48]. Fibrotic processes often cause chronic diseases such as bronchiolitis obliterans
and interstitial fibrosis [147]. A follow-up examination of 197 cases 10 years after a
single heavy exposure revealed chronic bronchitis in almost 60% of the patients to be
the leading late sequela [35]. Due to the diverse and complex respiratory disorders
which often consist of different individual characteristics the term “mustard lung”
was established [44]. Beyond these feared organ-specific effects, the risk of infection
is generally increased by a dose-dependent internal suppression of immunocompetent
cells and barrier disorders of the primarily affected tissue [53]. Especially at high-dose
levels systemic cytotoxic effects - involving fast dividing cells like those of the intestinal
mucosa and cells of the hematological system - and genotoxic and mutagenic impacts
were observed [18]. Long-term consequences are recurrent infections and malignancies
like acute myeloid leukemia and acute lymphocytic leukemia, but also weakness,
insomnia, headache, loss of appetite, nausea, vomiting and defective spermatogenesis,
that emerge partially even years later [53, 119, 136]. Progeny of SM-affected soldiers
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showed a significantly elevated overall manifestation of physical abnormalities and
disorders [1].
1.2.2 Sulfur Mustard - Case Report of Accidental Exposure
First-hand case reports of SM documenting the acute and chronological course of
symptoms are rare, since intoxication mainly occurs in wars and terroristic attacks
with very limited opportunities for follow-up examination or cohort stratification.
During our research we were able to examine a case of accidental exposure by
analyzing skin samples from an intoxicated male laboratory worker, who was involved
in a process of chemical plastic production. Until the incident it was not known
that SM was formed as an intermediate product in that specific process making a
certain type of plastic. Despite his wearing of several layers of clothing including his
laboratory coat, and his immediate change of apparel after noticing a leak in a tube,
SM was able to penetrate and affect his skin. Dermal contact with the agent was
not perceived at that moment and first symptoms in the central abdominal region
began approximately 30 minutes after the incident, resulting in an approximately 2
cm measuring erythema. The fact his left forearm was affected remained temporarily
unnoticed.
Figure 1.2: Right forearm 11 days after accidental exposure to sulfur mustard [123].
Both regions showed severe skin detachment over time. Even decontamination with
Previn® solution, treatment with hydrogen peroxide, cortisone ointment and repeti-
tive disinfectant measures could not prevent grave blistering and ulceration with the
necessity of extensive surgical debridement and split-skin grafting two weeks after
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the event, covering parts of the abdominal and ventral thoracic region.
Figure 1.3: Abdominal region 10 days after accidental exposure to sulfur mustard
[123].
The full report was published by Schmidt et al. [123].
1.2.3 Chlorambucil - Side Effects
Clinical presentation of patients during therapy with medically applied alkylating
agents is different, but several systemic effects appear similar [126]. While a dose-
dependent reversible myelosuppression in the context of treatment of leukemia is
intended, the effects on other organ systems complicate continuous usage and limit
the therapy [103]. Cbl treated patients generally show milder side effects since
the chemical compounds are less toxic; furthermore, production and application
is thoroughly supervised. Like many other chemotherapeutic drugs it potentially
causes diverse unwanted side effects in the gastrointestinal and central nervous
system; it can also lead to unwanted effects on skin and hair, damage to the liver
and the reproductive system as well as lung fibrosis and anemia [5, 144]. Boosted
activation of peripheral blood leucocytes can cause vascular tissue damage and organ
dysfunction [24]. Chronic consequences include severe diseases. In several studies
during 1981-1987 it was shown that the incidence of leukemia among with Cbl
treated polycythemia vera patients was significantly higher and rose with increased
pharmaceutical dose and duration of therapy [15]. A similarity between Cbl and
SM is their ability to affect endothelial cells [66, 122]. Their importance is further
discussed in section 1.4.
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1.3 Appearance, Chemical Structure and Molecular Effects
Alkylating agents can be characterized by their general property of being „capable of
covalently attaching an alkyl group to a biomolecule under physiological conditions“[8].
SM is a colourless or pale yellow and at room temperature oily liquid with a high lipid
solubility and low volatility; it is usually deployed via aerosol, and can in its impure
form have a scent of mustard or garlic and a darkened colour [18, 75, 113]. SM has a
melting point of 14°C and a vapor pressure of 0.11mmHg at 25°C. It is heavier than
air and accumulates under moderate conditions in air layers near the ground [82].
SM is a classified group 1 carcinogen [98]. Its toxic potential is attributable to its
high reactivity [4]. The molecule is pictured in figure 1.4.
Figure 1.4: Structural formula of sulfur mustard created with ChemSketch.
Major consequences on a molecular level are loss of cell integrity and disruption
of transcription and replication [70, 102]. Enhanced inflammatory response and
initiation of necrotic and apoptotic cell death can be triggered [53, 71, 109]. These
effects complicate wound healing and tissue repair.
Cbl is a chemotherapeutic drug applied orally in tablet form. It is less electrophilic
than SM, containing a nitrogen atom instead of the sulfide, and is - due to the
aromatic ring’s electron withdrawing capacity - less reactive, which permits a longer
half-life in serum and facilitates oral administration [25, 50]. The molecule is pictured
in figure 1.5.
Figure 1.5: Structural formula of chlorambucil created with ChemSketch.
Cbl is about 98% plasma-bound and becomes rapidly metabolized to phenyl acetic
acid mustard (PAAM) [121]. Its cytostatic and immunosuppressive properties are
based upon abnormal base pairing and cross linkage of DNA and RNA strands with
subsequent interference with replication especially during the S-cyclus leading to
apoptosis [47, 146]. Therefore, fast-dividing cells including endothelial precursors are
at particular risk [122].
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1.4 Epigenetics and Endothelial Cells
1.4.1 Epigenetics - General Information
Epigenetics is a relatively new scientific field that has been treated with increasing
interest in recent years. It was established to describe processes that connect
the previously separately-treated areas of developmental biology and genetics [57].
Alongside the well known term ‘genotype‘, the epigenetic equivalent ‘epigenotype‘
was coined [57]. While the genotype remains in a fairly stable configuration, the
epigenotype, as a second entity responsible for gene expression, is more dynamic and
inconsistent, reacting to cellular stimuli or metabolic requirements [42, 74]. These
stimuli include, for example: physical exercise, diet and exposure to chemicals [86,
90]. However, despite being modifiable, environmental influences may sometimes
lead to enduring epigenetic changes and change of gene expression through epigenetic
modifications seems to be inheritable as well [55, 105, 143]. The transmission of
epigenetic patterns to descendants is called transgenerational inheritance [86]. In
terms of diagnosis and treatment, difficult illnesses like cancer or autoimmune diseases,
but also neurodegenerative and psychological disorders, behavioral plasticity and
addiction have been related to epigenetic aetiologies [20, 90]. The term ‘epigenetics‘
comprises alterations in gene expression that are not related to the base sequence of
DNA itself, but rather to chromatin organization and maintenance [60]. This includes
histone posttranslational modifications, DNA methylation and the involvement of
RNA-based mechanisms [79, 83]. Figure 1.6. shows a graphical illustration of these
three mechanisms of gene regulation.
Figure 1.6: Epigenetic mechanisms of gene regulation.
(1) DNA methylation (depicted as red balls) involves the covalent mod-
ification of cytosine in the context of CpG dinucleotides to define the
‘fifth base of DNA‘ 5-methyl-cytosine. (2) Posttranslational modifications
of the histone amino terminal tails (depicted as light and dark blue
balls) are myriad and can importantly affect the physical properties and
higher-order compaction of chromatin. (3) RNA-based mechanisms have
recently emerged as important regulators of chromatin structure and
gene expression (depicted as red strands coating chromatin) [83].
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Histones, as the principal structural proteins of eukaryotic chromosomes, help to
package the DNA to fit inside the nucleus [23, 130]. Histone modifications are key
components of transcriptional regulation, modulating the chromatin structure [31,
96]. More precisely, correlations of modifications regarding chromatin structure
and function play a significant role in directing the level of chromatin compaction
and mediating functional pathways influencing the readout of distinct regions of
the genome [42]. Histone modifications are also conducive to genome stability by
signalling DNA damage and initiating the assembly of repair foci [88]. Furthermore,
they enable a histone code with the potential to extend the information of the genetic
code [64]. Common histone modifications include acetylation and methylation,
which were found to contribute to control of stem cell maintenance, differentiation
and function [62, 96]. Relevant enzymes hereof are histone methyltransferases
(HMTs), histone acetyltransferases (HATs) and deacetylases (HDACs) [49, 77]. The
balance between methylation and acetylation status plays an important role in
gene accessibility [97]. While histone acetylation leads to a relaxed chromatin state
and thereby enables transcriptional activation, deacetylation is linked to chromatin
compaction and transcriptional inactivation [94]. Overall, histone methylation is the
major component of chromatin modification; it is controlled and maintained by SET
domain proteins [76]. Histone methylation is generally associated with transcriptional
repression and occurs mainly on histones H3 and H4 [27, 54]. H3 and H4 are part
of four core histone proteins forming an octamer as part of the nucleosome [61].
Changes in H3 and H4 under the influence of SM were specifically investigated in our
research. Another important epigenetic modification is DNA methylation. Mainly
occurring at the C-5 position of cytosine within CpG dinucleotides, methylated
cytosine is considered to be the principal epigenetic tag that in regulatory regions
probably prompts the inactivation of the corresponding gene like an on-off switch
[87, 94]. The result is the creation of 5-methylcytosine (5-mc). This process is
described by the term ‘hypermethylation‘ [84]. DNA methyltranferases (DNMTs) are
key enzymes which promote this modification. Further oxidation by TET-proteins
leads to 5-hydroxymethylcytosine (5-hmc), which is mainly found in neuronal and
embryonal stem cell chromatin [22]. 5-hmc was also found to be associated with labile
nucleosomes [94]. The oxidation of 5-methylcytosine to 5-hydroxymethylcytosine
is considered to be an initial step in DNA demethylation pathways [149]. These
complexes are often referred to as 5th (5-mc) and 6th (5-hmc) DNA bases [116]. DNA
methylation fulfills different functions in mammalian organisms. Heavily methylated
genes are less likely to be translated into mRNA [86]. If normal, DNA methylation
contributes to chromosomal stability, X-chromosome inactivation, imprinting and
compartmentalization of chromatin [37]. It is involved in the developmental and
transcriptional regulation of tissue-specific gene expression and contributes to gene
silencing [33, 73, 148]. Phenotypic variations and disease susceptibility are associated
with it [148]. DNA methylation patterns can guide specific proteins to corresponding
target sites [139]. Serving also as epigenetic memory, DNA methylation status is
regarded to be more stable than other epigenetic modifications [90]. Aberrant DNA
methylation can have severe consequences, such as disruption of imprinting and
x-chromosome inactivation, as well as erroneous cloning [37]. It is an important factor
in the development of various diseases especially cancer [139]. Tumor cells frequently
show global genomic hypomethylation leading to the increased activity of oncogenes,
while promotor regions of tumor suppressor genes exhibit a state of hypermethylation
[86]. It’s been proposed that similar changes occur in cardiovascular and immune
disease [37]. In addition to the aforementioned modifications, RNA-based mechanisms
are involved in epigenetic control. This includes interfering on the level of chromatin
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and on the post-transcriptional level as they form a powerful surveillance system
dealing with suspect transcription events [58, 84]. It has been proposed that there
exist various layers of RNA-based regulation including non-coding RNA (ncRNA) [51].
NcRNA, structurally subdivided into small (sncRNA) and long (lncRNA) entities,
can as active regulators modulate gene transcription and thereby influence gene
expression [51, 141]. These units contribute to mechanisms such as gene silencing,
DNA demethylation, RNA interference, imprinting and gene co-suppression [86].
Recent scientific discoveries underlined their importance as key players in the process
of carcinogenesis [38]. The increasing evidence of the contribution of ncRNA to the
genesis and progression of many other diseases and their feature to be potentially
approached with drug therapy makes them therapeutically interesting [141]. However,
the exact roles of ncRNA are not yet completely understood, which still complicates
the development of therapeutics [141].
1.4.2 Epigenetics and Endothelial Cells
Several studies indicate the involvement of epigenetic pathways in the control of
vascular endothelial function. It is presumed that epigenetic mechanisms act as
mediators of environmental influences on vascular endothelial gene expression through
the regulation of factors which can predispose to vascular diseases [79, 83]. Epigenetic
mechanisms were found to substantially contribute to the regulation of endothe-
lial progenitor cell (EPC) tasks [40]. EPCs are considered crucial for successful
neovascularization and wound healing [29]. They are for example involved in the
process of neovascularization in different diseases like retinopathy, vascular diseases
and myocardial ischemia [72]. While endogenous endothelial progenitor cells are
important to initiate the body´s own vasculogenesis, therapeutically applied exoge-
nous endothelial progenitor cells can be of benefit to patients, as e.g. initiators of
revascularization after ischemic injury [40]. Human endothelial colony-forming cells
(ECFCs), pretreated ex vivo with epigenetic drugs, triggered enhanced formation of
capillary-like networks and accelerated restoration of perfusion, while maintaining
responsiveness to signals from the environment, which also may prevent blood-vessel
overgrowth [39]. Current research also includes various therapeutic approaches in
diabetic wound healing and peripheral arterial disease (PAD) [41].
1.4.3 Endothelial Cells and Sulfur Mustard
Endothelial cell migration-mediated vasculogenesis and angiogenesis are vital factors
in the healing process of ischaemic tissues and complex wounds caused by toxic
chemical substances [85, 132]. While many investigations about mechanisms and
measures in the process of wound healing after contact with SM until now focused
on keratinocytes and fibroblasts, newer studies confirmed alkylating agents impair
the integrity of blood vessels and their regeneration [122, 124]. SM leads to altered
endothelial morphology and increased capillary leakage [6]. Impairment of tissue
repair might be aided by the dysfunctional and reduced migration and proliferation
of endothelial cells. Considering the importance of endothelial progenitor cells for
wound healing, EECs present a reasonable in vitro approach [142]. The effects of SM
on endothelial cells are subject to continuous study. In 1996 Dabrowska et al. showed
that SM severely damages endothelial cells and underlined the important differences
in the apoptotic and necrotic processes involved, as well as their correlation with
intracellular ATP-levels [26]. Morphologic differences of control endothelial cells and
cells exposed to 500 µM are depicted in figure 1.7.
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Figure 1.7: Micrographs of Wright–Giemsa-stained endothelial cells. (A) Control
endothelial cells. (B) Cells exposed to 500 µM SM, after 5 hrs. With an
increase of chromatin condensation (arrow) and a partly irregular cell
array. [26].
Recent research suggests that SM has negative effects on vascularization and en-
dothelial tube formation e.g. in the pathophysiology of SM-based eye damage [100,
131].
1.4.4 Sulfur Mustard and Epigenetics
Recent studies underlined the importance of epigenetic mechanisms in the develop-
ment of SM-induced cellular dysfunction and long-term effects [74, 105]. Epigenetic
modifications were supposed to be responsible for chronic consequences like the clini-
cal picture of the mustard lung [59]. However exact patterns of modified DNA-related
molecules could barely be identified; a comprehensive understanding of the epigenetic
role of short and long-term effects remained absent [81, 102].
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2 Objectives of the Presented Thesis
The primary purpose of this study was to confirm the epigenetic contribution of
SM-caused pathology with a special focus on its long-term effects and to identify
potential therapeutic targets that enable the development of causal preventative and
symptomatic therapies.
The main questions the thesis addresses are:
• To which specific doses of SM is it possible to expose EECs so that they
maintain the ability of several cell divisions?
• Which epigenetic modulators and patterns are modified in affected cells and
what are the differences to non-exposed cells?
• Do different patterns persist over time, and if so, do they stay stable for several
cell divisions?
• Are there any congruent results between in vitro and in vivo affected cells?
• What are potential epigenetic targets for therapeutical intervention?
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3.1 Epigenetic Modulations in Early Endothelial Cells and
DNA Hypermethylation in Human Skin After Sulfur
Mustard Exposure
Steinritz, Dirk; Schmidt, Annette; Balszuweit, Frank; Thiermann, Horst; Simons,
Thilo; Striepling, Enno; Bölck, Birgit; Bloch, Wilhelm, Toxicology Letters, 26 of
February 2016, Vol. 244, pp. 95-102
In order to approach the investigation of epigenetic changes that potentially occur in
affected early endothelial cells, it was necessary to figure out at which concentrations
to treat these cells with SM while maintaining their capacity for subsequent in
vitro cultivation. The first step was to investigate the cell viability under influence
of SM through XTT-based colometric assay. The LC50 was reached at 11,7 µM.
Remarkably, to achieve an appropriate survival rate among early endothelial cells
for up to 4 passages - as further described in section 3.2 - we also had to establish
very low concentrations of 0.5 µM (~1/20 of LC50) and 1.0 µM (~1/10 of LC50).
Higher concentrations of 23.5 µM (~2 x LC50) and 50 µM (~5 x LC50) were set
in comparison in the short-term groups 24 hours post exposure. In this study
78 genes related to epigenetic pathways in EECs were analyzed in vitro. Besides,
we were able to compare the results to skin samples from an accidentally to SM
exposed laboratory worker. Applied investigation techniques comprised epigenetic
chromatin modification enzymes PCR array, DNA extraction, detection of global DNA
methylation in vitro and DNA methylation in human skin tissue. The results were
statistically analyzed. SM significantly changed various of the examined epigenetic
modulator genes and global DNA methylation status in the affected skin samples
compared to non-exposed control skin. In the in vitro tests genes were analyzed that
encode e.g. DNA methyltranferases and histone methyltransferases, acetyltransferases
and deacetylases. Overall 37 genes remained unaltered whereas 41 underwent either
up- or downregulation. The low doses caused more changes in gene regulation (22 and
29) than the high doses (10 and 10). DNA methylation status showed a significant
increase. Remarkably, after contact with high doses of SM (23.5 µM, 50 µM) DNA
methylation appeared to decrease again in comparison to the low doses (0.5 µM, 1
µM). The skin samples partly showed an even stronger increase of 5-mc than the in
vitro tests but the range of variation of DNA methylation levels strongly increased as
well, so that statistical significance was not achieved [127, 133]. The key findings can
be summarized as follows: (I) Under influence of SM complex regulation patterns of
epigenetic modulators could be validated and (II) global DNA methylation increased
in vitro and in vivo in different cell types.
Epigenetic modulations in early endothelial cells and DNA
hypermethylation in human skin after sulfur mustard exposure
Dirk Steinritza,b,*, Annette Schmidta,c, Frank Balszuweita, Horst Thiermanna,
Thilo Simonsa, Enno Strieplingd, Birgit Bölckc, Wilhelm Blochc
aBundeswehr Institute of Pharmacology and Toxicology, 80937 Munich, Germany
bWalther-Straub-Institute of Pharmacology and Toxicology, Ludwig-Maximilians Universität München, 80336 Munich, Germany
cDepartment of Molecular and Cellular Sports Medicine, German Sports University, 50933 Cologne, Germany
dDepartment of Handsurgery, Plastic and Microsurgery, Burn Center, BG Trauma Hospital Hamburg, 21033 Hamburg, Germany
H I G H L I G H T S
 Sulfur mustard induced epigenetic modulations were explored in early endothelial cells.
 78 Genes related to epigenetic pathways and global DNA methylation were investigated.
 SM exposure resulted in complex epigenetic perturbations and DNA methylation in vitro.
 Increased DNA methylation was found in SM exposed human skin one year after exposure.
 Epigenetic modulations may be responsible for SM-induced long-term health effects.
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A B S T R A C T
Victims that were exposed to the chemical warfare agent sulfur mustard (SM) suffer from chronic dermal
and ocular lesions, severe pulmonary problems and cancer development. It has been proposed that
epigenetic perturbations might be involved in that process but this has not been investigated so far.
In this study, we investigated epigenetic modulations in vitro using early endothelial cells (EEC) that
were exposed to different SM concentrations (0.5, 1.0, 23.5 and 50 mM). A comprehensive analysis of 78
genes related to epigenetic pathways (i.e., DNA-methylation and post-translational histone modifica-
tions) was performed. Moreover, we analyzed global DNA methylation in vitro in EEC after SM exposure as
a maker for epigenetic modulations and in vivo using human skin samples that were obtained from a
patient 1 year after an accidently exposure to pure SM.
SM exposure resulted in a complex regulation pattern of epigenetic modulators which was
accompanied by a global increase of DNA methylation in vitro. Examination of the SM exposed human
skin samples also revealed a significant increase of global DNA methylation in vivo, underlining the
biological relevance of our findings. Thus, we demonstrated for the first time that SM affects epigenetic
pathways and causes epigenetic modulations both in vivo and in vitro.
ã 2015 Elsevier Ireland Ltd. All rights reserved.
1. Introduction
Sulfur mustard (SM, bis(2-chloro-ethyl) sulfide, CAS No. 505-
60-2) is a chemical warfare agent (CWA) that was first used during
World War I. Later it was deployed in warfare in the Middle East
resulting in a large number of victims (Ghabili et al., 2010).
Exposure to this compound causes affection of skin, eyes, lungs and
systemic effects (Kehe et al., 2009b). Acute dermal symptoms are
most common and are characterized by erythema, burning
sensation, itching, vesication, ulceration, wound healing disorder
and pigmentation disorder (Graham and Schoneboom, 2013).
However, most victims suffer from a plethora of chronic health
effects of varying severity (Emadi et al., 2012; Ghabili et al., 2010;
Kehe and Szinicz, 2005; Rowell et al., 2009). Common problems
being reported in casualties include dermal symptoms, chronic
* Corresponding author at: Bundeswehr Institute of Pharmacology and Toxicolo-
gy, 80937 Munich, Germany.
E-mail address: dirk.steinritz@lrz.uni-muenchen.de (D. Steinritz).
http://dx.doi.org/10.1016/j.toxlet.2015.09.016
0378-4274/ã 2015 Elsevier Ireland Ltd. All rights reserved.
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ocular lesions, severe pulmonary problems and cancer develop-
ment (Doi et al., 2011; Easton et al., 1988; Graham and
Schoneboom, 2013; Hosseini-khalili et al., 2009; Rowell et al.,
2009).
Although not fully understood, the pathophysiology of
acute SM toxicity is much more elucidated than the chronic
health effects. Several mechanisms, e.g., alkylation of
biological macro-molecules including DNA, excessive DNA-repair,
induction of cell death, oxidative stress, activation of MMP,
disturbed cell signaling -just to name a few- have been identified
that contribute to acute toxicity (Bhat et al., 2000; Debiak et al.,
2009; Kehe et al., 2009a; Ries et al., 2009; Rosenthal et al., 2003;
Steinritz et al., 2009). However, these mechanisms cannot explain
SM induced lesions that occur sometimes decades after the initial
exposure (Ghabili et al., 2010; Ghanei et al., 2010), especially with
respect to the fact that intact SM, its biotransformation products
and protein adducts have a very limited half-life in vivo and are
eliminated within some weeks after exposure (Barr et al., 2008;
Black et al., 1997; Li et al., 2013). A meaningful pathophysiological
explanation for delayed SM induced chronic health effects is
lacking.
It has been proposed that SM induced chronic health
effects may be associated with epigenetic perturbations (Kork-
maz et al., 2008a,b) but this has not been investigated so far.
“Epigenetics” refers to the temporal and spatial control of gene
activity without altering the underlying DNA nucleotide se-
quence. Epigenetic modifications – including methylation,
acetylation, phosphorylation, and ubiquitination amongst others
– alter the accessibility of DNA to the transcription machinery
and therefore influence gene expression. Especially aberrant DNA
methylation was found to be associated with human diseases
including cancer (Jones and Baylin, 2002; Robertson, 2005).
Methylation of cytosine in CpG dinucleotides is probably the
most important covalent modification of DNA, resulting in
transcriptional repression (Bird, 2002). Post-translational mod-
ifications of histones (e.g., acetylation, methylation and phos-
phorylation) are additional mechanism for the regulation of gene
activity (Lee et al., 2010).
A plethora of proteins are known or predicted to modify
genomic DNA and histones thereby regulating gene expression.
Proteins mediating such modifications include DNA methyltrans-
ferases, histone acetyltransferases, histone methyltransferases,
SET domain proteins, histone phosphorylating proteins, proteins
for histone ubiquitination, DNA/histone demethylases and histone
deacetylases. These proteins are summarized as “epigenetic
modulators”. There is considerable evidence suggesting that
epigenetic mechanisms mediate the development of chronic
health effects by modulating a plethora of genes such as expression
of pro-inflammatory cytokines, interleukins, tumor suppressor
genes or oncogenes (Shanmugam and Sethi, 2013). Moreover,
epigenetic pathways have been linked to the control of vascular
endothelial function (Fraineau et al., 2015; Lewis et al., 2014;
Matouk and Marsden, 2008) and endothelial dysfunction has been
observed in various cardiovascular and pulmonary diseases
including Asthma, COPD and chronic bronchitis (Ives et al.,
2014; Vukic Dugac et al., 2015). Remarkably, these chronic diseases
are frequently observed after SM exposure (Ghabili et al., 2010;
Razavi et al., 2013; Rowell et al., 2009). In this study, we exposed
early endothelial cells (EEC) to different SM concentrations to
explore whether SM influenced epigenetic pathways in EEC and
affected global DNA methylation in vitro. In addition, we analyzed
global DNA methylation in SM exposed human skin samples. These
samples were obtained from a patient who accidentally exposed
himself to a small amount of pure SM at the abdomen and thorax
region and who was subjected to a surgical revision approx. one
year after the accident.
2. Material and method
2.1. Cell culture and incubation with SM
Early endothelial cells (EEC) were obtained from differentiated
murine embryoid bodies (for details see (Schmidt et al., 2009;
Schmidt et al., 2004)) through magnetic-activated cell sorting
(MACS) on day 7 after start of differentiation. MACS was performed
using a mini-MACS system with MS separation columns (Miltenyi
Biotec, Bergisch Gladbach, Germany) as described earlier (Dainiak
et al., 2007; Schmidt et al., 2004a). The PECAM-1 positive fraction
of cells was cultured on gelatine-coated dishes in DMEM,
(Dulbecco’s Modified Eagle medium) supplemented with 15%
heat-inactivated fetal calf serum (FCS), 50 U/ml penicillin, 50 U/ml
streptomycin, 200 mM L-glutamine, 100 mM b-mercaptoethanol,
and 1% MEM (non-essential amino acids (GIBCO-BRL, Gaithers-
burg, USA)). After 2–3 weeks, these PECAM-1 positive EEC were
passaged for the first time and afterwards once till twice a week.
Cells were used to passage 8. Cells were handled under sterile
conditions and cultivated with 5% CO2 at 37 C and 95% humidity.
SM (purity >99%, approved by NMR) was obtained from TNO (The
Hague, The Netherlands) and diluted in ethanol. For dose-finding
experiments EEC were exposed to SM with concentrations ranging
from 0 to 500 mM. For assessment of epigenetic changes, EES were
exposed with concentrations of 0.5, 1.0, 23.5 and 50 mM SM.
Controls were treated with ethanol (2.5m) in DMEM. All SM
exposure experiments were conducted at the Bundeswehr
Institute of Pharmacology and Toxicology.
2.2. Cell viability
EEC were seeded in 96-well plates at a density 50,000 of cells
per well and grown under standard conditions for 24 h. DMEM was
removed and cells were exposed to sulfur mustard at concen-
trations ranging from 0 to 500 mM in DMEM. Controls were treated
with ethanol (2.5m) in DMEM. After 1 h medium was renewed and
cells were grown for additional 24 h. Cell vitality was then
determined using the XTT assay (Roche, Switzerland). Non-linear
regression of dose-response curves was conducted using Graph-
PadPrism v5.01 software. 4 Independent biological experiments
with 4 technical replicates were conducted.
2.3. Epigenetic chromatin modification enzymes PCR array
2.3.1. Total RNA isolation
EEC were exposed to SM (0.5, 1.0, 23.5 or 50 mM) or treated with
ethanol (2.5m) for 1 h. After 24 h total RNA was extracted from
control and SM exposed EEC using the RNeasy1 Mini Kit (Qiagen,
Hilden, Germany), according to the manufacturer’s instructions.
Genomic DNA was degraded by DNase-on column treatment with
RNase-free DNase set (Qiagen, Hilden, Germany). The purity of
extracted RNA was assessed by measuring the optical density (OD)
at wavelengths of 230 nm, 260 nm and 280 nm using a NanoDrop1
ND-1000 spectrophotometer (NanoDrop Technologies, Wilming-
ton, USA). Absorbance ratio at 260/280 nm and 260/230 nm was
used to assess the purity of the RNA samples.
2.3.2. cDNA synthesis using the RT2 first strand kit
Total RNA was transcribed into cDNA using the RT2 First Strand
Kit (SABioscience/Qiagen, Hilden, Germany) according to the
manufacturer’s instructions. In brief, volumes corresponding to
1 mg of total RNA were mixed with 2 ml of genomic DNA (gDNA)
elimination buffer in a nuclease-free PCR tube. RNAse-free H2O
was added to a final volume of 10 ml. After thorough vortexing, the
mixture was incubated for 5 min at 42 C to degrade any gDNA in
the samples. Afterwards samples were placed on ice for at least
96 D. Steinritz et al. / Toxicology Letters 244 (2016) 95–102
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1 min. Then, 10 ml of the reverse transcription mix was added to
each tube. The mixture was gently resuspended and tubes were
placed in a thermocycler (FlexCycler2, Analytik Jena, Germany) and
incubated at 42 C for 15 min. Then, the thermocycler was
immediately heated to 95 C for 5 min to stop cDNA synthesis
by inactivation of the reverse transcriptase and degradation of
remaining RNA. 91 ml of DEPC–water were added to each vial
containing 20 ml cDNA solution resulting in a total volume of
111 ml. Samples were stored at 20 C until further analysis.
2.3.3. qRT-PCR using the RT2 profilerTM PCR array
102 ml cDNA solution (see Section 2.3.2), 1248 ml RNase-free
water and 1350 ml 2 RT2 qPCR SYBR1 Green Mastermix
(consisting of HotStart DNA Taq polymerase, PCR buffer, dNTP
mix (dATP, dCTP, dGTP, dTTP) and SYBR1 Green dye, SABioscience/
Qiagen, Hilden, Germany) were mixed. After thorough stirring,
25 ml were transferred into each well of the RT2 ProfilerTM PCR
Array plate (PAMM-085Z, SABioscience/Qiagen, Hilden, Germany)
containing the pre-dispensed forward and reverse primers for each
individual gene. The plate was carefully sealed with an optical
adhesive film and liquids in the wells were briefly spun down at
2500 rpm for 20 s (VWR PCR Plate Spinner, Darmstadt, Germany).
Then, the plate was placed in a Mx3005P Cycler (Stratagene Agilent
Technologies, Santa Clara, CA, USA) and qRT-PCR detection was
performed using the a two-step cycling program. The first step was
conducted for 10 min and 95 C for heat activation of HotStart Taq
DNA polymerase. Next, 40 cycles each with 15 s at 95 C and 1 min
at 60 C was performed to first disassociate DNA double strands
and then amplify DNA and data acquisition. Melting curves were
recorded to verify specific production of a single PCR product for
each individual gene and exclude the formation of primer dimers
and other unspecific PCR products. Further quality controls were
performed using an excel-based RT2 RNA QC PCR Array template
(http://www.sabiosciences.com/pcrarraydataanalysis.php) that
allowed evaluation of CT-values of specific PCR controls measured
with every PCR plate. Only data that met the control requirements
(reverse transcriptase activity, positive PCR control and negative
genomic DNA control) were used for further analysis. 5 house-
keeping genes included in the arrays were used for normalization
of data.
2.3.4. PCR data evaluation
Threshold cycle (CT) values for each well were calculated using
the real-time cycler software. An Microsoft Excel1-based spread-
sheet evaluation (provided by SABiosciences http://www.sabio-
sciences.com/pcrarraydataanalysis.php) was used to calculate the
mRNA expression in SM exposure groups in relation to the ethanol
control group using the 2DDCT method. Changes in gene
expression were reported in a biologically meaningful way,
especially for decreased gene expressions, by dividing 1/2DDCT.
Expression changes > 1 had not to be converted. The cut-off for
gene regulation was set to 2-fold (2 for down-regulation and +2
for up-regulation). Microsoft Excel1 was used to generate a heat
map and to calculate intersections between the individual groups.
Hierarchical clustering analysis was performed using Cluster 3.0
with distance measures based on the Pearson correlation and
visualized using TreeView. Protein Association Network Analysis
was performed using STRING (www.string-db.org/).
2.4. DNA extraction
EEC were exposed to SM (0.5, 1.0, 23.5 or 50 mM) or treated with
ethanol (2.5m) for 1 h. Cells were detached by Accutase (PAA
Laboratories GmbH, Linz, Austria), followed by a centrifugation at
200  g for 10 min. Cells were diluted in DMEM to 3  106 cells to
meet the genomic DNA extraction kit (NORGEN Biotek
Corporation, Canada) criteria. Genomic DNA was extracted
according to the manufacturer’s protocol. In brief, cells were lysed
by adding 200 ml Digestion Buffer, 15 ml Proteinase K and 20 ml
RNase A and subsequent incubation at 55 C for 1 h. After cell lysis,
samples were vortexed for 15 s before 200 ml Buffer SK was added
and the samples were thoroughly vortexed. Then 200 ml ethanol
(96%) was added. After vortexing the whole 600 ml volume per
sample was transferred to a spin column assembled with a
provided collection tube. Next, tubes were centrifuged at 5200  g
for 2 min. Afterwards, columns (with DNA bound to the resin) were
washed twice with 500 ml wash solution. Finally, columns were
placed in new eppendorf tubes and DNA was eluted by adding
200 ml Elution Buffer B to the resin bed and centrifugatuin at
3000  g for 1 min and for an additional 2 min at 14,000  g. DNA
concentration was quantified by UV spectrophotometry using a
NanoDrop1 ND-1000 spectrophotometer (NanoDrop Technologies,
Wilmington, DE, USA) measuring the absorption at A260/280. DNA
concentrations were calculatedasthe mean of the threeruns foreach
sample. Samples were stored at 80 C until further analysis.
2.5. Global DNA methylation
Global DNA methylation was assessed by determination of 5-
methylcytosine (5-mC) using an ELISA-based assay (5-mC kit;
Zymo Research, California, USA) following the manufacturer’s
instructions. In brief, a standard curve was generated based on 7
standards. Each DNA samples was adjusted with 5-mC Coating
Buffer to a final DNA concentration of 1 ng/ml. 100 ml of the sample
was denatured at 98 C for 5 min using a thermocycler and was
transferred on ice for 10 min. The entire sample volume (100 ml)
was then used for coating a 96-well plate (1 h, 37 C). After 3
washing with 200 ml of 5-mC ELISA Buffer, 100 ml antibody mix
(consisting of anti-5-methylcytosine and the secondary antibody
in 5-mC ELISA Buffer) was added to each well. Samples were
incubated at 37 C for 1 h. Plates were washed 3 with 200 ml 5-mC
ELISA Buffer. 100 ml of Horseradish Peroxidase Developer were
added to each well and incubated at room temperature. Absorption
was measured using a plate reader (Multiskan FC, Thermo
Scientific, USA) at 405 nm. 5-mC levels of all samples were
normalized to ethanol controls that were set to 1.
2.6. DNA methylation in human tissue
During an accident in a chemical plant a worker exposed
himself to a small amount of pure sulfur mustard at the abdomen
Fig. 1. Sulfur mustard cytotoxicity in EEC.
EEC were treated with SM using concentrations from 0 to 500 mM. Cell viability was
assessed 24 h post exposure using the XTT assay. Gray dotted lines represent
concentrations of 0.5, 1.0, 23.5 or 50 mM SM that were used in subsequent
experiments. Data represent means  SD from 3 independent experiments each
with 4 technical replicates.
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Fig. 2. Changes of epigenetic chromatin modification enzymes in EEC after SM exposure.
EEC were exposed to ethanol (2.5m) or SM (0.5, 1.0, 23.5 or 50 mM). Changes of epigenetic modulators was assessed 24 h post exposure using a PCR array profiling the
expression of key genes encoding enzymes known or predicted to modify genomic DNA and histones to regulate chromatin accessibility and therefore gene expression. The
heat map (A) displays changes in gene regulation (green = upregulation; red = downregulation) compared to the ethanol control group. Proteins that exhibited a > 2 fold
change in gene regulation in at least one group (41 genes) are displayed in black letters whereas unchanged genes (37 genes) are displayed in grey letters. Significant changes
(p < 0.05) are marked with asterisks. Low dose exposure groups (0.5 and 1.0 mM SM) and high dose exposure groups (23.5 and 50 mM) exhibited distinct differences: in low
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and thorax region. Due to a wound healing disorder at the
abdominal site, a skin graft was performed 14 days after the
incident. The thorax area healed spontaneously. Approx. one year
after exposure, a surgical revision was conducted at all former
exposure sites at the explicit request of the patient, who feared a
tumor development. During surgery, the formerly non-operated
thorax site (thorax (central)) with adjacent tissue (thorax
(peripheral)) and the transplant with adjacent tissue (abdomen
(peripheral)) were removed. In addition, the patient approved
removal of a control skin area from the upper leg (unexposed skin)
that was definitively not exposed to sulfur mustard. Skin samples
from each skin area were divided into 3 samples and immediately
deep frozen after removal. Tissue samples were sliced in 7 mm
section thickness with a microtome (Leica CM1900, Leica Micro-
systems, Nussloch, Germany) and homogenized into fine powder
in liquid nitrogen. 300 ml of Digestion Buffer A was added to 20 mg
of the sample according to the manufacturer’s protocol from the
Genomic DNA Isolation Kit (NORGEN Biotek Corporation, Thorold,
Canada). Slicing and Homogenation was repeated 3 times, thereby
obtaining 3 technical replicates from each skin specimen. Global
DNA methylation was assessed using the MethylFlashTM methyl-
ated quantification colorimetric assay (Epigentek, Farmingdalte,
USA).
2.7. Statistics
Significant changes in gene expression were calculated based
on a Student’s t-test of the replicate 2(DCt) values for each gene in
the control group and SM exposure group using a spreadsheet
provided by SABiosciences (http://pcrdataanalysis.sabiosciences.
com). Significance was assumed at p < 0.05. Means and standard
deviations were calculated and significance was tested by One-
Way ANOVA followed by Bonferroni’s correction for multiple
comparison using GraphPad Prism 5.04 (GraphPad Software).
Significance was assumed at p < 0.05. Principle component
analysis (PCA) was performed using a free-available Excel1 add-
in from NumericalDynamics.com (www.numericaldynamics.com).
3. Results
3.1. Sulfur mustard cytotoxicity in EEC
Exposure of EEC to different concentrations (0–500 mM) of SM
and assessment of cell viability 24 h post exposure revealed a LC50
of 11.7 mM (Fig. 1). For further experiments SM concentrations of
0.5 (1/20 of LC50), 1.0 (1/10 of LC50), 23.5 (2  LC50) and 50
(5  LC50) were chosen. 3 Independent experiments, each with 4
technical replicates were conducted.
3.2. Epigenetic chromatin modification enzymes
Changes in gene regulation of epigenetic modulating enzymes
in response to SM were investigated 24 h post exposure using a
qPCR array. 78 Genes including DNA methyltransferases, histone
acetyltransferases, histone methyltransferases, SET domain pro-
teins, histone phosphorylating proteins, proteins for histone
ubiquitination, DNA/histone demethylases, histone deacetylases
were explored. From the 78 investigated genes, 37 remained
unchanged in all exposure groups whereas 41 genes were up- or
down-regulated > 2 fold in at least one group. Exposure of EEC to
0.5 mM SM affected the regulation of 22 genes with 7 up-regulated
and 15 down-regulated genes. 29 Genes were differentially
regulated at 1.0 mM SM with 23 down-regulated and 6 upregulated
genes. At higher SM concentrations the number of regulated genes
decreased to 10 genes at both 23.5 mM and 50 mM. 4 Genes were
down- and 6 genes were up-regulated at 23.5 mM SM and 5 genes
were down- and 5 genes were up-regulated at 50 mM SM.
Investigated house-keeping genes (e.g., actin, GAPDH) revealed
no significant changes in any SM exposure group. Comparing the
group mean differences by paired one-way ANOVA and Sidak
correction for multiple testing revealed no significant differences
between the 0.5 and 1.0 mM as well as no difference between the
23.5 and 50 mM SM exposure groups. However, a significant
difference between the mean of 0.5 and 1.0 and the mean of the
23.5 and 50 mM SM exposure group was detected (p < 0.001). This
distinctive difference was also found in a principle component
analysis. Therefore, data was merged to a low dose exposure group
(0.5 and 1.0 mM SM groups) and a high dose exposure group (23.5
and 50 mM groups) thereby matching similar regulated genes
within the two groups. In the low dose exposure group 17 genes
were differentially regulated with 12 down- and 5 up-regulated
genes. In contrast, only 4 genes exhibited a differential expression
in the high dose exposure group with 2 down- and 2 up-regulated
genes. Obviously, more genes were affected in the low dose
exposure and predominantly down-regulated. No gene showed a
consistent regulation in all groups. However, Usp22 was down-
regulated in low dose exposure groups whereas it was up-
regulated in high dose exposure groups. SM induced down-
regulation of Dnmt3a and Kdm4c was detected at SM concentra-
tion of 1.0 and above and followed a dose response relationship. A
down-regulation of Ncoa3 was observed already at 0.5 mM SM
while increasing SM concentrations mitigated this effect. Dnmt1,
Dnmt3a, Hat1, Hdac9, Hdac11, Kdm4c, Kdm6b, Ncoa3, Prmt8, Set1b
and Whsc1 revealed most pronounced changes. Results are
summarized in Fig. 2 in form of a heat map (Fig. 2A), as a Venn
diagram (Fig. 2B and C), as a principle component analysis (Fig. 2D)
and are listed in Table S1. Fold-change values and protein clusters
are given in Supplementary Table S1.
3.3. 5-Methylcytosine levels in EEC after SM exposure
5-Methylcytosine (5-mc) levels in EEC 24 h increased signifi-
cantly after exposure to 1.0 and 23.5 mM SM compared to ethanol
controls. After exposure to 0.5 mM SM, 5-mc increased slightly
(approx. 1.2 fold), but not significantly. Both 1.0 and 23.5 mM SM
resulted in an approx. 2.5 fold increase of 5-mc levels. At 50 mM an
approx. 2 fold increase was observed, however, level of significance
was not reached. All 5-mc levels were normalized to 5-mc levels in
ethanol controls. 3 independent experiments each with 3 technical
replicates were conducted (Fig. 3).
3.4. 5-Methylcytosine levels in SM exposed human tissue
Global DNA methylation (5-methylcytosine, 5-mc) was
assessed in all samples. Data were normalized to control
(unexposed skin) levels. Formerly exposed skin tissue from the
thorax as well as potentially exposed but not primarily removed
adjacent tissue revealed significant higher levels of 5-mc
dose exposure groups significant more genes were regulated (29 genes up- or downregulated compared to only 4 up- or downregulated genes within the high dose exposure
group). No gene was up- or down-regulated in all groups. However, 3 genes (Dnmt3a, Ncoa3, Kdm4c) were down-regulated following a dose response relationship over three
groups. Relations between each data set for up-regulated genes (B) or down-regulated genes (C) are given in the Venn diagram. Shades correspond to the number of genes per
intersection. Both Venn diagrams confirm that low dose and high dose exposure groups exhibit distinct differences with regard to epigenetic pathways. A principle
component analysis (D) revealed that the low dose exposure group is distinctively different from the high dose exposure group. All data represent means from 3 independent
biological experiments per condition.
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compared to control skin. Relative 5-mc levels were determined
with 15.2  3.0 for the thorax central skin sample, 17.3  2.3 for the
peripheral thorax skin sample, 17.0  2.0 for the adjacent
abdominal tissue. The transplant, which was excised as full
thickness skin, showed distinct, but strongly varying levels of 5-mc
(6.0  5.1), thus missing level of significance (Fig. 4).
4. Discussion
Prior preliminary work has proposed the involvement of
epigenetic mechanisms in the pathophysiology of SM induced
chronic health effects (Korkmaz et al., 2008a,b; Nourani et al.,
2015). Remarkably, the histone deacetylase inhibitor Trichostatine
A resulted in a significant reduction of interstitial, pulmonary
edema, hemorrhage, emphysematous changes and reduction of
inflammation in mechlorethamine (HN2, nitrogen mustard)
induced toxic lung injury in vivo (Korkmaz et al., 2008b). However,
underlying epigenetic pathways were not investigated in that
study. It is well accepted that epigenetic pathways are involved in
physiological processes like wound healing (Lewis et al., 2014) but
epigenetic perturbations are also involved in the development of
chronic diseases including pulmonary disorders and cancer (Ito
et al., 2005; Jones and Baylin, 2002; Robertson, 2005). Moreover,
endothelial dysfunction was observed in a plethora of pulmonary
and cardiovascular diseases. Based on that findings and due to the
fact that endothelial cells are severely affected by SM (Schmidt
et al., 2009; Steinritz et al., 2010, 2011), we focused on epigenetic
pathways in early endothelial cells after SM challenge in the
presented study.
The term “epigenetics” refers to the temporal and spatial
control of gene activity without affecting the underlying DNA
nucleotide sequence. A huge number of different proteins
including DNA methyltransferases, histone acetyltransferases,
histone methyltransferases, SET domain proteins, histone phos-
phorylating proteins, proteins for histone ubiquitination, DNA/
histone demethylases and histone deacetylases are known or
discussed to be involved in this process. These proteins are
summarized as “epigenetic modulators”. Changes of epigenetic
modulators after challenge with different SM concentrations were
assessed in our study using a PCR-based array that allowed the
investigation of 78 different genes. Our results provide striking
evidence that a single SM exposure significantly influenced
epigenetic modulators 24 h after SM exposure. Remarkably, SM
concentration of 0.5 and 1.0 mM caused explicit more changes in
gene regulation (22 and 29 regulated genes) compared to 23.5 and
50 mM SM (10 and 10 regulated genes) (Table S1). This observation
is of relevance: cells exposed to high SM concentrations (23.5 and
50 mM are both above the LC50) will most probably undergo cell
death within 24 h or later on. Thus, epigenetic perturbations in
these cells are unlikely to persist over time and a sustainable
“epigenetic risk” arising from these cells seems unlikely. However,
cells exposed to low SM concentrations (0.5 and 1.0 mM are
considerably below the LC50) will not undergo cell death but will
persist and thus epigenetic changes may have significant
consequences during further lifespan.
Pronounced differences between the low dose and high dose
exposure groups were observed in our experiments. SM resulted in
down-regulation in the majority of affected genes in the low dose
exposure group (0.5 and 1.0 mM SM) with some exceptions. An up-
regulation of Dnmt1 was observed already after exposure to
0.5 mM SM and even more pronounced at 1.0 mM SM. In contrast,
Dnmt1 levels were found mainly unchanged in the high-dose SM
exposure group (23.5 and 50 mM SM). Dnmt1 is considered to
maintain DNA methylation during replication (Jin and Robertson,
2013). This strengthens our hypothesis that particularly low SM
concentrations may bear an epigenetic risk. Surprisingly, although
a significant increase of global DNA methylation was observed in
our experiments, an up-regulation of Dnmt3a or Dnmt3b, which
are considered as responsible for DNA de novo methylation, was
not evident. It should be noted that Dnmt1 can cause de novo DNA
methylation itself or is at least involved in the regulation of it
(Athanasiadou et al., 2010; Vertino et al., 1996). Moreover, protein
Fig. 3. Global DNA methylation in EEC.
EEC were exposed to ethanol (2.5m) or SM (0.5, 1.0, 23.5 or 50 mM). 24 h after
exposure the content of 5-methylcytosine (5-mc) was assessed. 5-mc levels were
normalized to ethanol controls. Exposure to SM at 1.0 and above resulted in a
significant increase of 5-mc levels. Data represent means  SD from 3 independent
biological experiments each with 3 technical replicates per group. Statistical
significance is indicated by asterisks (*p < 0.05 vs. control).
Fig. 4. DNA methylation in exposed human tissue.
Different specimens were obtained from a patient who had exposed himself to a
small amount of pure sulfur mustard at the abdomen and thorax region. Due to a
wound healing at the abdominal site, a skin graft was performed. The thorax area
healed spontaneously. Approx. one year after exposure, a surgical revision was
conducted. The transplant with adjacent potentially exposed but not excised areas
(abdomen (peripheral)) and the formerly untreated thorax site (thorax (central))
and adjacent tissue (thorax (peripheral)) were removed. In addition, a control skin
sample from the upper leg that was definitively not exposed to SM was obtained.
Global DNA methylation (5-methylcytosine, 5-mc) was assessed in all samples. Data
were normalized to control (unexposed skin) levels. Formerly exposed skin tissue
(thorax) as well as potentially exposed but not primarily removed tissue (abdomen
peripheral) revealed significant higher levels of 5-mc compared to control skin. The
transplant, which was excised as full thickness skin, showed a distinct, but not
significant increase of 5-mc levels. Bars represent means  SD from 3 technical
replicates per sample. Statistical significance is indicated by asterisks (*p < 0.001 vs.
unexposed skin).
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activity is not only dependent on protein expression levels but can
also be modulated by post-translational modifications and protein
interactions. For example, a non-covalent interaction of Dnmt1
with PARP-1 was shown that influences Dnmt1 activity and thus
DNA methylation state (Caiafa et al., 2009). Remarkably, SM was
found to activate PARP-1 (Debiak et al., 2009; Kehe et al., 2009a)
suggesting a functional link with regard to Dnmt1 activity. A
STRING analysis (Supplementary Fig. S1A) revealed that Dnmts are
linked to chromatin organizing enzymes and DNA damage
response genes which both may modulate DNA structure and
epigenetic status. In addition, DNA methylation patterns result
from both methylation and demethylation processes (Li, 2013). It
can be speculated that SM induced active or passive DNA
demethylation also contributed to the complex DNA methylation
pattern. Recently, it has been demonstrated that Dnmts can also act
as demethylases. Mammalian Dnmt1, Dnmt3a, and Dnmt3b can all
convert 5-mC to cytosine (Chen et al., 2013). Moreover, histone
demethylases (i.e., KDM1) were shown to be involved in
maintenance of global DNA methylation (Wang et al., 2009).
Although KDM1 was mainly unaffected in our experiments, other
KDMs (e.g., KDM4c, KDM5b, KDM6b) were down-regulated in SM
exposed EEC. Although unproved at the moment, it can be
speculated that a link between other KDMs than KDM1 and the
global DNA methylation pattern may exist. Interestingly, a
functional link between KDM4c and the transcription factor
Nanog was found through STRING analysis (Supplementary
Fig. S1B).
Our results provide compelling evidence that epigenetic
perturbations after SM exposure are of biological relevance as
demonstrated by significantly increased 5-mc levels in vivo even
one year after an accidental human exposure. Although the exact
exposure dose was unknown, it can be estimated that the scenario
resembles a “low-dose” exposure as the patient exposed himself to
a few drops of pure SM. Increased hypermethylation, especially
within tumor suppressor genes, seems to be associated with
cancer development (Esteller, 2002). Although a significant
increase of dermal cancer after SM exposure has not been
reported, it is well known that pulmonary malignancies and
cherry hemangiomas (abnormal proliferation of blood vessel)
occur. We therefore recommended a cancer screening (including
skin) at close intervals in addition to the regular follow up
screenings for the exposed patient.
Regarding other epigenetic modulators changes in gene
regulation were observed for Hat1, Hdac9, Hdac11, Kdm4c, Kdm6b,
Ncoa3, Prmt8, Set1b and Whsc1. In general, the interpretation of
epigenetic modulator patterns is challenging as many functions
and pathways are not fully elucidated. Ncoa3 was shown to be
essential for maintenance of embryonic stem cell (ESC) pluri-
potency (Wu et al., 2012). Down-regulation of Ncoa3 resulted in
impaired differentiation potential of ESC. In our experiments,
Ncoa1 and 3 were significantly down-regulated in the low-dose SM
exposure group. Again, as these cell will not undergo cell death,
long-term adverse effects might arise thereof. This is in line with
our previous studies that exactly identified an impaired differen-
tiation potential of murine ESC after exposure to alkylating agents
(Schmidt et al., 2009; Steinritz et al., 2010).
Our results demonstrated an upregulation of Whs1c in all
groups but especially in 23.5 mM exposed EEC. Here, an 11-fold
increase was observable, which was the highest change in protein
regulation of all investigated genes. Whsc1 has been linked with
cancerogenesis (Saloura et al., 2015) and Chek2, a protein that
elicits DNA repair, cell cycle arrest or apoptosis in response to DNA
damage (Supplementary Fig S1C). Although 23.5 mM is above the
LC50, that was determined at 11.7 mM SM 24 h after exposure, and
thus most of the affected cell will undergo cell death within that
period or just after, it cannot be ruled out that some of these cells
will survive and might promote tumor development.
Suv420h1 was shown to have direct impact on cell migration
(Yokoyama et al., 2014). Our experiments revealed a distinct down-
regulation of this SET domain protein in the low-dose SM exposure
groups. This is in line with our recent findings showing that
migration of EEC was highly affected by low concentrations of the
alkylating compound chlorambucil (Steinritz et al., 2014) and with
prolonged wound healing after SM exposure in vivo (Ghanei et al.,
2010; Graham et al., 2002).
Changes of other epigenetic modulators observed in our
experiments mainly addressed post-translational histone mod-
ifications (e.g., acetylation, methylation, phosphorylation, ubiq-
uitinilation, demethylation and deacetylation). Although the
“histone code” has been intensively investigated during the last
decade (Jenuwein and Allis, 2001; Ng and Cheung, 2015) and
impressive progress has been made, the phenomena of chromatin
organization and transcriptional regulation has not been entirely
unraveled. Therefore, future work will focus on (i) SM induced
post-translational histone modifications, (ii) the overall stability of
epigenetic modulations (on both mRNA and protein levels) and (iii)
their biological consequences.
Summing up, the results of our study demonstrated for the first
time that SM exposure of EEC resulted in a complex regulation
pattern of epigenetic modulators which was accompanied by a
global increase of DNA methylation. Especially low-dose SM
exposures caused comprehensive changes of the investigated
epigenetic regulative genes. Examination of human skin samples
one year after an accidental SM exposure revealed a significant
increase of global DNA methylation, underlining the biological
relevance of our findings. Our results are encouraging and future
work will focus on SM induced histone modifications, the overall
kinetics of epigenetic changes and therapeutic interventions e.g.,
the use of Dnmt inhibitors. This could eventually lead to the
development of new therapeutic strategies against SM induced
chronic health effects as well as SM induced wound healing
disorders.
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Sulfur Mustard [µM]
0.5 1.0 23.5 50 Gene Gene Class
+3.34 +4.78 -1.81 -1.13 Dnmt1 DNA Methyltransferases
+2.50 +2.44 -1.08 +1.20 Aurkb Histone Phosphorylation
+3.13 +5.25 +1.31 +1.81 Hat1 Histone Acetyltransferases
+2.41 +2.07 +1.15 +1.79 Esco2 Histone Acetyltransferases
+1.99 +1.63 +1.36 +2.18 Aurka Histone Phosphorylation
+3.72 +2.42 +1.02 +1.32 Prmt7 Histone Methyltransferases
+2.82 +1.04 +1.10 +1.36 Aurkc Histone Phosphorylation
+1.82 -1.53 +2.21 +2.58 Smyd1 Histone Methyltransferases
+1.13 +1.02 +3.37 +1.98 Setd8 SET Domain Proteins
+2.27 +1.09 +5.34 +1.78 Prmt8 Histone Methyltransferases
+1.94 +1.41 +11.26 +1.44 Whsc1 SET Domain Proteins
-1.55 +2.25 +1.28 +2.28 Setd6 SET Domain Proteins
-1.46 -3.09 -2.45 -9.07 Dnmt3a DNA Methyltransferases
-1.60 -2.16 -4.67 -6.50 Kdm4c DNA / Histone Demethylases
-1.22 -1.46 -1.84 -3.31 Smyd3 Histone Methyltransferases
-1.31 -3.70 -1.00 -1.07 Kdm5c DNA / Histone Demethylases
-3.32 -7.10 -1.40 -1.49 Kdm6b DNA / Histone Demethylases
-2.34 -2.95 -2.04 -1.71 Ncoa3 Histone Acetyltransferases
-1.35 -2.14 -1.15 -1.17 Cdyl Histone Acetyltransferases
-1.91 -2.56 -1.03 -1.77 Hdac4 Histone Deacetylases
-4.23 -5.73 -1.05 -2.41 Ncoa1 Histone Acetyltransferases
-2.96 -3.31 -1.08 -1.37 Kdm5b DNA / Histone Demethylases
-2.59 -3.63 -1.17 -1.28 Suv420h1 SET Domain Proteins
-1.92 -3.00 -1.08 -1.36 Setd5 SET Domain Proteins
-7.73 -6.60 -1.71 -1.80 Hdac9 Histone Deacetylases
-1.55 -1.69 -2.36 -1.73 Dnmt3b DNA Methyltransferases
-2.63 -1.31 -1.20 -2.01 Kat2b Histone Acetyltransferases
-2.51 -1.89 -1.55 -1.09 Ncoa6 Histone Acetyltransferases
-1.59 -2.02 +1.06 -1.14 Hdac8 Histone Deacetylases
-2.71 -4.09 +1.04 -1.24 Setd1b SET Domain Proteins
-2.76 -3.54 +1.14 -1.18 Nsd1 SET Domain Proteins
-2.02 -2.46 -1.04 +2.01 Setd1a SET Domain Proteins
-1.11 -2.42 +1.00 +1.01 Dot1l Histone Methyltransferases
-1.47 -3.27 +1.85 +1.53 Kdm4a DNA / Histone Demethylases
-2.08 -5.18 +1.40 +1.31 Hdac11 Histone Deacetylases
-1.99 -2.79 +1.22 +1.26 Setd7 SET Domain Proteins
-2.61 -2.55 +1.09 +1.09 Mysm1 Histone Ubiquitination
-2.20 -2.93 +2.41 +2.79 Usp22 Histone Ubiquitination
-2.04 -1.25 +1.17 +1.37 Ube2b Histone Ubiquitination
-1.09 -2.02 +1.78 -1.30 Ciita Histone Acetyltransferases
-1.27 -1.03 +2.37 -1.20 Rnf2 Histone Ubiquitination
Fold-change values of genes that were regulated >2 fold in at least one group. Up-regulated genes are illustrated in 
green and down-regulated genes in red. Other than in the heat map (Fig. 2A) colors do not indicate gradations in 
gene regulation. Hierarchical clustering with distance measures based on the Pearson correlation is indicated by a 
dendogram.
Supplementary Table 1: Data table of SM induced gene regulation in EEC
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A protein association network analysis was conducted 
for selected epigenetic modulators using the STRING 
database (www.string-db.com). 
(A) Dnmt1, Dnmt3a or Dnmt3b were used as input vari-
ables. The result indicated a direct interaction with his-
ton modifying proteins (e.g. Hdac1, Hdac2). In addition, 
other proteins involved in the organization of chromatin 
structure (e.g. Baz2a, Smarca5, Suz12) were also found 
to interact with Dnmts. Moreover, DNA damage res-
ponse proteins (e.g. Pcna) were associated within the 
functional protein network.
(B) Kdm4c as input variable revealed that expression of 
the transcription factor Nanog, which is responsible for 
self-renewal of undifferentiated embryonic stem cells 
while loss of Nanog function causes differentiation, is 
discussed to depend on Kdm4c expression.
(C) Whsc1, the protein with highest change in regulati-
on of all investigated genes, was found to be involved in 
collagen biosynthesis (Plod1-3) but also associated with 
Chek2, a protein that elicits DNA repair, cell cycle arrest 
or apoptosis in response to DNA damage.
Color legend (for details see www.string-db.com):
green = activation
red = inhibiton
blue = binding
purple = post-translational modification
yellow = expression
black = reaction
A
B
C
Supplementary Figure 1: Protein Association Network Analysis using STRING
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3.2 Sulfur Mustard-Induced Epigenetic Modifications Over
Time - A Pilot Study
Simons, Thilo; Steinritz, Dirk; Bölck, Birgit; Schmidt, Annette; Popp, Tanja; Thier-
mann, Horst; Gudermann, Thomas; Bloch, Wilhelm; Kehe, Kai, Toxicology Letters,
16 of November 2017, Vol. 293, pp. 45-50
Additionally to short-term exposure of early endothelial cells to SM (section 3.1), we
were able to investigate epigenetic changes over time. In particular, we analyzed the
effects of SM on the global DNA methylation state, histone acetylation and histone
di-methylation at exemplary histone sites (acetyl/di-methyl H3-K9, acetyl/di-methyl
H3-K27, di-methyl H3-K36, acetyl H4-K8) 24 hours after exposure as well as after
additional 2 and 4 cell passages. Also the skin samples of the accidentally exposed
patient (section 3.1) were examined on the same terms and compared to the in
vitro tests. Applied investigation techniques used to detect epigenetic modifications
included ELISA based assay, immunohistochemical procedures, immunofluorescence
labelling as well as confocal microscopy of tissue sections. Subsequently we conducted
a statistical analysis. After an initial decrease of 5-mc levels as a marker for the DNA
methylation state in the low exposure groups (0.5 µM and 1.0 µM) we found that
5-mc levels increased after 4 cell passages as well as in the obtained skin samples.
Histone modifications appeared not to be consistent presenting strong variations over
time and dose. Acetylation tended to return to control level over time (H3-K27),
decrease (H3-K9) or increase (H4-K8). Also histone di-methylation (H3-K9, H3-K27,
H3-K36) appeared to return to control level or to decrease over time evincing strong
variations and depending onto the cell type (EECs or skin cells). The key findings
can be summarized as follows: (I) SM exposure caused a significant increase of 5-mc
levels over time in EECs as well as in the skin samples, and (II) occurrence and
persistence of histone modifications remained statistically unsignificant.
Contents lists available at ScienceDirect
Toxicology Letters
journal homepage: www.elsevier.com/locate/toxlet
Full Length Article
Sulfur mustard-induced epigenetic modifications over time − a pilot study
Thilo Simonsa, Dirk Steinritza,b, Birgit Bölckc, Annette Schmidta,d, Tanja Poppa,b,
Horst Thiermanna, Thomas Gudermannb, Wilhelm Blochc, Kai Kehea,e,⁎
a Bundeswehr Institute of Pharmacology and Toxicology, 80937, Munich, Germany
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Long-term health effects
A B S T R A C T
The chemical warfare agent sulfur mustard (SM) can cause long-term health effects that may occur even years
after a single exposure. The underlying pathophysiology is unknown, but epigenetic mechanisms are discussed as
feasible explanation. “Epigenetics” depicts regulation of gene function without affecting the DNA sequence itself.
DNA-methylation and covalent histone modifications (methylation or acetylation) are regarded as important
processes. In the present in vitro study using early endothelial cells (EEC), we analyzed SM-induced DNA me-
thylation over time and compared results to an in vivo skin sample that was obtained approx. one year after an
accidental SM exposure. EEC were exposed to low SM concentrations (0.5 and 1.0 μM). DNA methylation and
histone acetylation (H3-K9, H3-K27, H4-K8) or histone di-methylation (H3-K9, H3-K27, H3-K36) were in-
vestigated 24 h after exposure, and after 2 or 4 additional cell passages. The human skin sample was assessed in
parallel. SM had only some minor effects on histone modifications. However, a significant and pronounced
increase of DNA methylation was detected in the late cell passages as well as in the skin sample. Our results
indicate that SM does indeed cause epigenetic modifications that appear to persist over time.
1. Introduction
Exposure to the chemical warfare agent sulfur mustard (SM; CAS-
Nr. 505-60-2) causes both acute and long-term health effects (Ghabili
et al., 2010). The underlying pathophysiology is still not understood.
Acute effects are supposed to be caused by DNA alkylation and the
consequences thereof. DNA adducts, however, are recognized by cel-
lular DNA damage response elements (Matijasevic et al., 2001) and cells
either initiate DNA repair processes or may activate cell death programs
in case of very severe DNA affections (Ruff and Dillman, 2007). In SM
exposure cases presenting mild symptoms, a complete recovery is
usually observed (Steinritz et al., 2016b). However, some patients de-
velop long-term and delayed clinical symptoms, even after a single
exposure (Balali-Mood et al., 2005; Ghanei and Harandi, 2007; Firooz
et al., 2011; Kehe et al., 2016). The reasons for those late effects remain
obscure and a meaningful pathophysiological explanation for delayed
SM-induced chronic health effects is still lacking. However, recent
studies have proposed epigenetic alterations or an imbalance of the
existing epigenetic pattern as possible cause (Korkmaz et al., 2008;
Imani et al., 2015; Steinritz et al., 2016a). “Epigenetics” describe
functionally relevant changes to the genome without direct mutational
modifications in the DNA sequence (Weinhold, 2006; Sharma et al.,
2010; Conaway, 2012). Epigenetic modifications can be grouped into
different categories: i) changes of the DNA methylation status, ii) his-
tone modifications, and iii) influence on protein synthesis by noncoding
RNAs like miRNA or long non-coding RNA (lncRNA) (Handy et al.,
2011; Du et al., 2015; Imani et al., 2015). In a previous in vitro study,
we have already demonstrated that exposure to SM, especially at very
low concentrations at which cell death is negligible, affected the ex-
pression of epigenetic modulators and the global DNA methylation
status of early endothelial cells significantly (Bloch et al., 2016, 2017;
Steinritz et al., 2016a). In the same study, we had the chance to in-
vestigate the global DNA methylation status of a human sample after an
accidental SM exposure. Here, a significant increase of 5-methylcyto-
sine (5-mC) was detected in the previous SM-exposed skin areas com-
pared to non-exposed skin samples indicating that SM indeed
https://doi.org/10.1016/j.toxlet.2017.11.010
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influenced DNA methylation and that these effects seem to persist
substantially (Steinritz et al., 2016a). Nevertheless, little is known
about the stability of epigenetic modifications over time. The persis-
tence of epigenetic differences− even over decades− associated with
prenatal exposure to famine is one example that indicates a high sta-
bility of such modifications (Heijmans et al., 2008; Talens et al., 2010),
while a longitudinal study of epigenetic variation in twins (Wong et al.,
2010) describes the opposite result. It is assumed that SM does induce
epigenetic modifications. However, this is difficult to investigate in vivo
because the individual epigenetic status before exposure is unknown in
the majority of cases and makes thus interpretation of epigenetic
modifications after exposure challenging. Thus, we have initiated an-
other in vitro study to investigate SM-induced epigenetic changes (DNA
methylation and histone modifications) over time, using a well-estab-
lished cell culture system with early endothelial cells, and compared
our results to a skin samples of a SM-exposure case.
2. Materials and methods
2.1. Cell culture
Early endothelial cells (EEC) were obtained from differentiated
murine embryoid bodies as described previously (Schmidt et al., 2004).
PECAM-1 positive fraction of cells (in the following named “MACS
cells”) were cultured on gelatine-coated dishes in DMEM (Dulbecco’s
Modified Eagle medium) supplemented with 15% heat-inactivated fetal
calf serum (FCS), 50 U/ml penicillin, 50 U/ml Streptomycin, 200 mM L-
glutamine, 100 mM b-mercaptoethanol, and 1% MEM (non-essential
amino acids (GIBCO-BRL, Gaithersburg, USA)). After 2–3 weeks, the
endothelial cells were passaged for the first time. Subsequently, cells
were split before reaching confluency and were used up to passage 8.
Cells were handled under sterile conditions and cultivated with 5% CO2
at 37 °C and 95% humidity.
2.2. In vivo material
SM-exposed human skin as well as control skin was obtained from a
patient that accidently exposed himself to SM and required skin deb-
ridement and a split-skin graft (Steinritz et al., 2016a). A subsequent
surgical procedure was conducted 1 year after the initial event. Skin
samples of the formerly SM-exposed area of the upper thorax, and
control skin from a definite non-exposed area from the thigh were
collected. The patient’s consent and approval of the ethic committee
was obtained in advance.
2.3. SM exposure
SM was made available by the German Ministry of Defense. A purity
of at least 99% was confirmed by NMR analysis. SM was diluted in
EtOH resulting in a 400 μM stock solution. The stock solution was
further diluted in DMEM directly before exposure and added to the cells
resulting in SM doses of 0.5 and 1.0 μM in accordance to our previous
study (Steinritz et al., 2016a). Controls were treated with EtOH (0.25
Vol-%).
2.4. Investigation of global DNA methylation (5-mC)
Global DNA methylation was assessed by determination of 5-me-
thylcytosine (5-mC) using an ELISA-based assay (5-mC kit; Zymo
Research, California, USA) following the manufacturer’s instructions.
Every DNA sample was diluted in the provided coating buffer to a final
concentration of 1 ng/ml. Denaturation of the DNA was done at 98 °C
for 5 min. Denaturated DNA was immediately transferred to ice for 10
min, then transferred to a 96-well plate. and the plate was incubated for
1 h at 37 °C. After three washing steps with the ELISA buffer, the an-
tibody mix was added. Samples were incubated for another 1 h at 37 °C.
Plates were then washed again 3-times with ELISA buffer. After de-
veloping the signal with HRP-developer solution, absorption was
measured at 405 nm using a plate reader (Multiskan FC, Thermo
Scientific, USA). Values were normalized to the 5-mC levels of the EtOH
controls or to the levels of the control skin. The 5-mC ratios were cal-
culated in relation to the absorbance, detected using an ELISA plate
reader, of the standard curve obtained from the positive controls at
405 nm wavelength.
2.5. Detection of histone-modifications
2.5.1. Immunocytochemistry
All cells were fixed after treatment ± intervention with 4 % par-
aformaldehyde in 0.1 M PBS for 25 min. and washed three times with
0.1 M PBS. The permeabilization of cells is an important point to fa-
cilitate the antibody binding to inner cell proteins. Therefore, the cells
were incubated 10 min with 0.25 % Triton-X 100 and 0.5 M NH4Cl in
0.05 M Tris-Buffered-Saline (TBS). The detergent Triton-X 100 per-
meabilizes the cell membrane while the NH4Cl reacts with free alde-
hyde groups to prevent an unspecific binding of the antibodies, fol-
lowed by rinsing with TBS (3 x 10 min). To prevent unspecific bindings
cells were incubated with 2 % bovine serum albumin (BSA) in 0.05 M
TBS (1 h at RT). Primary monoclonal antibodies against acetylated ly-
sine residues of histone 3, lysine 9 (Ac-H3-K9), Ac-H3-K27, Ac-H4-K8 or
against dimethylated lysine residues of histone 3, lysine 9 (DM-H3-K9)
as well as DM-H3-K27 or DM-H3-K36 (all antibodies were from Cell
Signaling and diluted 1:1000) were used. Cells and tissue samples were
incubated at 4 °C over night. The following day cells were rinsed with
TBS and then incubated with the corresponding biotinylated secondary
antibody, either goat anti-rabbit IgG (1:500 in 0.05 M TBS) for 1 h
followed by a streptavidin Alexa555 (1:500 in 0.05 M TBS) (life tech-
nologies, USA) for 1 h. Finally, staining with DRAQ5 in 0.1 M PBS was
done for 10 min to visualize the nucleus.
2.5.2. Immunofluorescence labelling and confocal microscopy of tissue
sections
The tissue slices were incubated with rabbit anti-AC H3-K27
(1:1000) for 24 h at 4° C. The sections were incubated with biotinylated
goat anti rabbit IgG (1:500) and with the Streptavidin Alexa 555
(1:500) for 1 h at RT, respectively. Staining of nuclear DNA staining
was done using DRAQ5 (1:2000). Control experiments were performed
in separate incubations by omission of the primary or secondary anti-
bodies. Two color fluorescent images were acquired on an LSM 510
META confocal microscope (Carl Zeiss, Oberkochen, Germany). The
543 nm excitation beam and 560–613 nm band-pass emission filter
were used to selectively view the red fluorochrome (for the identifica-
tion of Histone modification). The 633 nm excitation beam and
649–702 nm band-pass emission filter were used to selectively view the
far-red fluorochrome (for the identification of DRAQ5). The measure-
ment of the staining intensity was performed by using the Image J
Software (National Institutes of Health, Bethesda, Maryland, USA). The
blue colored nucleus was manually selected and then both channels
633 nm (blue; DRAQ5) and 543 nm (Red; Alexa 555) were measured. In
the program, the signal strength and the area, that were averaged over
the whole nucleus, for each channel and nucleus were stored in a da-
tabase. For every condition (control, Treatment) 50 scans were per-
formed. Dermal tissue slices were stained according to the same pro-
tocol. Epidermal cell layers were categorized into basal cells (B),
intermediate cells (I) and apical cells (A) and were evaluated in-
dependently.
2.6. Statistics
Statistically significant differences between the means of respective
groups were determined by one-way ANOVA and Tukey-Kramer cor-
rection for multiple testing using GraphPad Prism v7.03 (GraphPad
T. Simons et al. Toxicology Letters 293 (2018) 45–50
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Software, La Jolla, USA). P-values< 0.01 were regarded as significant.
Experiments were repeated at least three times (n = 3) for the in vitro
experiments, while only a single in vivo sample (n = 1) derived from
the only patient was available. Specimens from the thorax region,
which was initially exposed to SM, and a control region were divided
into three parts that were investigated separately, resulting in three
technical replicates. In-depth statistical analysis was not conducted for
the in vivo samples.
3. Results
3.1. Effects of SM on the global DNA methylation state
Changes of global DNA methylation state was assessed by determina-
tion of overall 5-mC levels by ELISA technique. After exposure of EEC
(initial cell passage was defined at “Px” at the beginning of the study) with
SM, 5-mC levels decreased significantly within 24 h in both SM groups
(Fig. 1, Px0.5 μM= 0.604 ± 0.484, Px1 μM= 0.347 ± 0.217). After cul-
tivation for another two passages, global 5-mC levels returned to control
levels in both SM exposure groups (Fig. 1, Px
+ 20.5 μM= 1.061 ± 0.598, Px + 21 μM= 0.884 ± 0.466). Re-
markably, after another two passages, relative 5-mC levels significantly
increased again in both SM groups, but especially in the 1.0 μM SM group
(Fig. 1, Px + 41 μM= 2.8 ± 2.552). The variation in this group was more
pronounced than in the 0.5 μM SM group (Fig. 1, Px
+ 40.5 μM= 1.985 ± 1.186).
In the human in vivo samples, that were obtained approx. one year
after an accidental SM exposure, 5-mC levels of the unexposed skin
were comparable to the in vitro control groups. However, 5-mC levels
increased significantly and pronounced in the formerly SM-exposed
skin area (Fig. 1, in vivoSM = 8.916 ± 1.021).
3.2. SM-induced histone modifications
Acetylation and di-methylation at three exemplary histone-sites
were investigated by immunocytochemistry. In general, all investigated
post-translational modifications exhibited some changes. However,
changes were not consistent and showed variations regarding time and
SM exposure concentrations. A clear dose dependency could not be
observed in the in vitro samples.
3.2.1. Histone acetylation
Histone acetylation that is linked to gene activation was in-
vestigated by immunohistochemical staining of acetyl H3-K9 (Fig. 2A),
acetyl H3-K27 (Fig. 2B), and acetyl H4-K8 (Fig. 2C).
Exposure of EEC to SM resulted in a significant increase of acetyl
H3-K9 within 24 h after exposure with a pronounced increase in the 0.5
μM SM group (Px0.5 μM= 2.119 ± 0.766). With ongoing cell culturing
at Px + 2 and Px + 4, acetyl H3-K9 levels returned almost to control
levels. Some statistical differences were detected; however, differences
were small. At Px + 4, no differences were found between control cells
and cells formerly exposed to 1.0 μM SM. Basal acetyl H3-K9 levels
were homogenously distributed in control skin. In the skin areas, that
were exposed to an unknown amount of SM approx. one year ago, a
weak decrease in acetyl H3-K9 levels was determined in the basal, in-
termediate and apical cell layers (B = 0.582 ± 0.527,
I = 0.572 ± 0.460 and A = 0.556 ± 0.359).
Regarding acetyl H3-K27, only very minor changes were observed.
Statistical differences between the SM groups and the control cells were
not detected 24 h after exposure (Px). In Px + 2 some differences were
evident, but a dose-dependency could not be observed. Cells, formerly
exposed to 0.5 μM SM exhibited a decrease of acetyl H3-K27 levels (Px
+20.5 μM= 0.483 ± 0.219), while exposure to 1.0 μM resulted in an
increase (Px +21 μM = 1.292 ± 0.385). After another two cell pas-
sages (Px + 4), there was again no difference between the SM groups
and control cells. In the 0.5 μM SM group, acetyl H3-K27 levels in-
creased compared to Px + 2 but were still significantly below those
levels in the 1.0 μM SM group. In the control skin, basal acetyl H3-K27
levels were homogenously distributed in all cell layers, in the same
manner as the acetyl H3-K9 distribution pattern. In the SM-exposed
skin, levels of H3-K27 were found significantly decreased in basal, in-
termediate and apical cell layers (B = 0.756 ± 0.743,
I = 0.697 ± 0.672 and A = 0.653 ± 0.493).
Stainings of acetyl H4-K8 revealed distinct variations regarding the
distribution of the raw values in all experimental groups. Due to this
effect, no relevant statistical differences were found in the in vitro ex-
periments. By trend, SM decreased acetyl H4-K8 levels 24 h after ex-
posure in Px (Px0.5 μM= 0.612 ± 0.49, Px1 μM= 0.351 ± 0.219).
The results suggest a dose-response relationship. Levels of acetyl H4-K8
returned to control levels in Px + 2 and Px + 4. Basal levels of acetyl
H4-K8 were again homogenously distributed in the non-exposed control
skin. In the SM-exposed skin, acetyl H4-K8 staining was strikingly en-
hanced in the intermediate and apical cell layers (I = 1.499 ± 1.059
and A = 1.439 ± 0.958). Here, a significant difference to the basal
cell layer of the control skin was observed. In the basal layer of the
exposed skin, an enhanced staining was noticed by trend, however, a
significant difference could not be identified (B = 1.161 ± 0.843).
3.2.2. Histone di-methylation
Histone methylation that is linked to gene silencing was in-
vestigated by immunohistochemical staining of di-methyl H3-K9
(Fig. 2D), di-methyl H3-K27 (Fig. 2E), and di-methyl H4-K36 (Fig. 2F).
SM exposure resulted in a significant increase of di-methyl H3-K9
levels in EEC 24 h after exposure in Px (Px0.5 μM = 1.397 ± 0.675,
Px1 μM = 1.511 ± 0.732). A dose-response relationship was noticed by
trend, however, at a p-value of 0.01 a statistical difference between 0.5
and 1.0 μM SM was not found. After additional two cell passages (Px
+ 2), no variation in the di-methyl H3-K9 levels were identified.
Fig. 1. Long-term global DNA methylation after SM exposure.
Early endothelial cells were exposed to sulfur mustard (SM) (0.5 or 1.0 μM) or sham-
treated with ethanol (Ctr). After 24 h (Px), global 5-mC levels were assessed by ELISA.
Cells were cultivated for two (Px + 2) or four (Px + 4) additional cell passages. Levels of
5-mC were assessed at each passage (Px, Px + 2, Px + 4). Human skin samples, obtained
approx. one year after an accidental SM exposure, were investigated in parallel. Results
from three independent experiments (n = 3) with a total number of 50 cells per group
and time point were analyzed and are visualized by Tukey boxplots (median, lower and
upper quartile, whiskers at 1.5 IQR, outliers as individual points). Horizontal brackets
encompass all groups with significant differences (p≤ 0.01) compared to the ethanol
control group or the control in vivo skin sample
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Another two cell passages (Px + 4) had no additional effect, however, a
significant difference between the 0.5 and 1.0 μM SM was found
(Px0.5 μM = 0.87 ± 0.354, Px1 μM= 1.116 ± 0.268). Basal levels of
di-methyl H3-K9 were homogenously distributed in the non-exposed
control skin. In the SM-exposed skin, basal cells revealed no difference
compared to basal cells of control skin, whereas intermediate and apical
cells exhibited lower levels (B = 0.830 ± 0.754, I = 0.758 ± 0.696
and A = 0.624 ± 0.579).
A comparable pattern was found for di-methyl H3-K27. In Px, no
differences were found between control cells and SM-exposed cells
(Px0.5 μM = 1.341 ± 0.645). In Px + 2, only 1.0 μM exposed cells ex-
hibited some increase of di-methyl H3-K27 levels (Px
+ 21 μM = 1.385 ± 0.627). However, di-methyl H3-K27 levels sig-
nificantly decreased in Px + 4 in both SM exposure groups compared to
control cells (Px + 40.5 μM= 0.594 ± 0.232, Px + 41 μM=
0.741 ± 0.214). Again, basal levels of di-methyl H3-K27 were homo-
genously distributed in the non-exposed control skin. Also, comparable
to the findings regarding di-methyl H3-K9, SM-exposed skin showed a
decrease of di-methyl H3-K27 that was found most dominant in the
apical cell layer (B = 0.679 ± 0.624, I = 0.724 ± 0.56 and
A = 0.554 ± 0.355).
Results regarding di-methyl H3-K36 exhibited no statistical differ-
ences in all in vitro and in vivo experiments. However, variations of the
relative signal values were found to decrease over time especially in the
SM exposure groups. While the distribution of di-methyl H3-K36 was
homogenous in all layers of the control skin, levels were decreased by
trend in all cell layers of formerly SM-exposed skin
(B = 0.89 ± 0.922, I = 0.851 ± 0.861 and A = 0.810 ± 0.739).
4. Discussion
Epigenetic modifications are proposed to cause various biological
phenomena and long-term health effects that are difficult to explain
otherwise. A good example are SM-induced delayed or long-term health
effects that can still occur years after a single exposure (Balali-Mood
et al., 2005; Kehe et al., 2016). While acute health effects seem to rely
on DNA alkylation and the biological consequences thereof, SM-in-
duced epigenetic DNA modifications are discussed to be responsible for
long-term effects (Korkmaz et al., 2008; Steinritz et al., 2016a). In
general, the concept of epigenetics describes affection of gene expres-
sion independent of DNA sequence transformation (Meyer and Widom,
2005; Matouk and Marsden, 2008). It is well accepted that epigenetic
information is inherited in plants (Hauser et al., 2011). If this holds also
true in mammals is debated controversially (Heard and Martienssen,
2014; Vaiserman, 2015; van Otterdijk and Michels, 2016). There is,
however, some good evidence that the individual epigenetic informa-
tion, that has been imprinted by e.g. environmental events, does persist
in the individuum (Heijmans et al., 2008; Baccarelli and Bollati, 2009;
Hashimoto et al., 2010). In this context, it is of utmost importance to
understand that epigenetic modifications are not in fact “static” but
may be highly dynamic over time (Reik, 2007; Bjornsson et al., 2008).
In a previous study (Steinritz et al., 2016a), we have successfully de-
monstrated that exposure to alkylating compounds affects epigenetic
modulators and 5-mC levels early after exposure. Results, that were
obtained from a human in vivo sample, also suggested a certain stability
of these modifications over time. Because in vivomaterial is rare or even
not available, a definitive answer to the hypothesis that SM-induced
epigenetic modifications do persist could not be given. Therefore, we
conducted the presented study that analyzed epigenetic modifications
in vitro over time and cell generations, i.e. over a period of six cell
passages. Moreover, we compared the in vitro results to the in vivo data,
again, obtained from the only available human sample in our lab.
While DNA methylation is accepted to be linked to gene silencing,
the role of histones and post-translational histone modifications with
regard to gene activity is less clear. It was assumed that histones are
mandatory for chromosome modelling, recent findings indicate that the
gross structure of chromosomes will even form without histones (Kakui
and Uhlmann, 2017). This may lead to the hypothesis that histones hold
a function that goes beyond maintaining chromatin structure, namely
regulating gene transcription. In general, histone methylation to var-
ious degree is thought to either inhibit or activate transcription while
histone acetylation may promote transcription (Kuo and Allis, 1998;
Jenuwein and Allis, 2001). Moreover, the balance between acetylation
and methylation is considered as crucial for gene accessibility (Ohzeki
et al., 2012). In addition, a precise link between histone modification
and an exact gene regulation has not been established so far. The bio-
logical relevance of a certain histone modification is therefore hardly to
predict. We have chosen to investigate histone H3 and H4 modifications
in our study, as histone H3 is discussed to be the most modified histone
in the epigenetic context and histone H4 is an important protein in the
structure and function of chromatin. Modifications of other histones
were not in the focus of the presented study. However, we have per-
formed some additional experiments including additional histone
modifications. All investigated histones showed the same dynamic in
our experiments, thus we do assume that SM-induced post-translational
histone modifications do not seem to play a major role with regard to
SM-induced epigenetic long-term effects. This hypothesis is underlined
by the in vivo results that do not exhibit dramatical changes in SM-
exposed skin compared to control skin. At this point, our results can be
interpreted in terms of that DNA methylation seems to be a key event
after SM exposure while histone modifications are not.
We must admit that our study exhibits a relevant shortcoming, that
must be addressed: we investigated EEC in the in vitro experiments and
compared the results with epidermal keratinocytes in the in vivo sam-
ples. One may argue that this is to compare apples and oranges. The
reason for that approach is, however, simple. The in vitro study was
conducted before we got hands on the human samples and evaluation of
endothelial cells in the human sample would have been highly chal-
lenging, as these cells are not highly abundant in histochemical sec-
tions. Nevertheless, we assume that our findings hold true for the
general situation after SM exposures.
Future experiments are currently planned that will use in vivo
models over a prolonged time to assess SM-induced epigenetic mod-
ifications. Moreover, due to the scientific progress it will be possible to
use highly sensitive and specific mass spectrometry methods to char-
acterize epigenetic DNA modifications (Bareyt and Carell, 2008) and to
identify possible epigenetic intermediates (Su et al., 2016) in more
detail.
In summary, our data suggest that SM does induce stable epigenetic
modifications. These are predominantly represented by DNA methyla-
tion while histone modifications seem to play a minor role only. In vivo
study should be conducted to validate the results of our pilot study and
Fig. 2. Long-term SM-induced histone modifications.
Post-translational histone modifications (acetylation or di-methylations) were investigated by immunocytochemistry either in vitro or in vivo. Early endothelial cells were exposed to sulfur
mustard (SM) (0.5 or 1.0 μM) or sham-treated with ethanol (Ctr). After 24 h (Px), cells were fixed, stained and investigated using a laser-scanning-microscope. Cells were cultivated for
two additional cell passages (Px + 2) and two further passages (Px + 4). Histone modifications (acetyl H3-K9 (A), acetyl H3-K27 (B), acetyl H4-K8 (C), di-methyl H3-K9 (D), di-methyl
H3-K27 (E), and di-methyl H3-K36 (F)) were assessed at each passage (Px, Px + 2, Px + 4). Human skin samples, obtained approx. one year after an accidental SM exposure, were
investigated in parallel. Levels of histone modifications were assessed in the epidermal basal cells (“B”), in intermediate cell layer (“I”) or in the apical cells (“A”). Results from three
independent experiments (n = 3) with a total number of 50 cells per group and time point were analyzed and are visualized by Tukey boxplots (median, lower and upper quartile,
whiskers at 1.5 IQR, outliers as individual points). Horizontal brackets encompass all groups with significant differences (p≤ 0.01) compared to the ethanol control group or the control
in vivo skin sample.
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to provide more insight into SM-induced epigenetic modifications that
may be responsible for SM long-term health effects.
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4 Summary and Outlook
4.1 Approach and Results
The goal of the research conducted was to examine the action of epigenetic mecha-
nisms and modifications in early endothelial cells after poisoning with SM, which
contribute to the acute and long-term effects patients have to suffer from. Of par-
ticular interest were affected cells that survived the primary contact with the agent
and persisted in an altered state. In contrast to cells that were affected by a high
dose of SM it is assumed that low-dose affected cells would not immediately go
through necrotic or apoptotic processes and that epigenetic cellular abnormalities
therefore may occur after subsequent cell divisions [133]. These viable but potentially
epigenetically modified cells might contribute to the observed long-term complications
of SM intoxication. Epigenetic alterations were identified by measuring changes of
several representative marker molecules and genes. Short-term and long-term changes
were examined separately. Applied analytic techniques included the usage of PCR
array, genomic DNA extraction kit, ELISA-based assay as well as immunofluores-
cent techniques. An exemplaric figure of cell nucleus analysis is pictured in figure 4.1.
Figure 4.1: Exemplaric figure of cell nucleus analysis using immunofluorescence. Line-
scan and data record by laser scanning mikroscope (Zeiss LSM 510). Scan
way (in µm) with 1000 measuring points each and detection of intensity
of Alexa 555 respectively DRAQ5 with consecutive tabular account.
Analysis of at least 50 cell cores of each treatment group.
We were able to identify certain epigenetic patterns. Histone modifications, in
particular methylation and deacetylation, which are important for transcriptional
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repression, were found persistently, but they exhibited substantial variations over
time and depending on the applied dose of SM, so that a clear pattern could not be
observed [16]. The results of the short-term and long-term in vitro investigations
showed some similarities, like the formation of 5-mC and 5-hmC. In the long-term
in vitro group the methylation status increased significantly over time and with
subsequent cell passaging in low-exposure groups (0.5 µM and 1 µM) [16]. Also
the skin samples exhibited changes in the DNA methylation status [123]. This puts
DNA methylation under the main focus [127]. There are five different types of DNA
methyltransferases (DNMTs), but only DNMT1, and DNMT3a and DNMT3b can
transfer methyl groups from the usual donor S-adenosylmethionine to DNA [80, 152].
Interestingly the ‘de novo‘ DNMTs DNMT3a and DNMT3b were not up-regulated
under influence of SM, so that this task was probably assumed by DNMT1 [80, 133].
4.2 Epigenetical Therapeutical Targets
By identifying certain epigenetic patterns of early endothelial cells which were
treated with SM in vitro and comparing them to the skin samples obtained, we
demonstrated possible medical targets and similarities between different cell types
[127]. There is no specific causal treatment available as of yet to approach the
observed epigenetic changes. Histone modifications and DNA methylation present
possible targets for eventual intervention. Histone-modifying enzymes, like e.g.
histone deacetylases (HDACs), were found to play fundamental roles as regulators of
differentiation and development of most cell types and interference in these processes
naturally raises concern [96]. But nevertheless a transient manipulation is regarded
to be useful [96]. Deacetylation of histones can therapeutically be blocked using
histone deacetylase inhibitors (HDACis) like trichostatine A (TSA). TSA showed
to be beneficial after intoxication with mechloretamine (MEC), a SM derivate; it
may reactivate genes that were silenced by the agent and thereby preclude further
damage [74]. Moreover, HDACis showed an effect on alternative splicing and might
thereby regulate transcriptional elongation [28]. DNA methylation status is of
special interest since our results presented significant changes under influence of
SM. An imaginable intervention would be the application of DNA methyltranserase
inhibitors (DNMTi). Described effects of this relatively new class of substances
comprise the arrest of tumor growth and cell invasiveness as well as induction of
differentiation [153]. By now the most common representatives are azacytidine (trade
name: Vidaza®) and decitabine (DAC, trade name: Dacogen®). Azacitidine was
approved 2004 by the FDA, decitabine followed in 2006 [91, 92]. They are used
for treatment of myelodysplastic syndromes, chronic myelomonocytic leukemia and
acute myeloid leukemia [30]. DAC (5-Aza-2-Deoxycitidin) - together with the local
anaesthetic procaine - showed to prevent DNA methylation and deacetylation and
was even able to counteract toxicity after SM intoxication in vitro [17]. Also natural
sources of DNMTis including flavonoids like epigallocatechin-3-gallate (EGCG),
curcumin or laccaic acid, are available and promising since unwanted side effects
are less common [20, 153]. Silibinin, another phytochemical and natural supplier of
DNMTis, was already used to mitigate SM toxicity - showing reduction of necrosis
and proinflammatory effects - but epigenetic changes were not analyzed in parallel
[10]. Hence, interventions with DNMTis could be a next step building upon our
results. Confirmation that these substances are also relevant in vivo in order to treat
SM intoxication has yet to be generated.
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4.3 Limitations and Conclusion
Regarding the study design we used, it has to be stated that it holds some limitations.
In the in vitro analysis we focused on endothelial progenitor cells as they are known
to play an important role in the process of wound healing [142]. During our in
vitro tests we received the information of the accidental exposure. Because of the
level of difficulty of extracting a sufficient number of endothelial cells out of surgical
skin samples we assessed the numerous and easy to identify keratinocytes in the in
vivo sample. To prove clinical evidence though, a higher number of cases of in vivo
samples would be needed and would ideally include the exact same cell type. Beside
the probability that the encountered changes persist over at least several cell divisions,
dynamic changes in epigenetic modifications over time were observed before, such
that further longitudinal research designs are recommended [148]. Nevertheless, the
partially congruent results strengthen the theory that modifications might appear
universally even in different cell types after exposure [127]. Other alkylating agents
such as Cbl showed similar effects in terms of strongly impairing endothelial cells and
potentially leading to dysfunctional vascularization and abnormal wound healing,
but intriguingly newer internal investigations of our working group showed distinct
differences between the provoked epigenetic patterns of SM and Cbl [122, 134]. In
conclusion it can be stated that we could corroborate the hypothesis that epigenetic
mechanisms are involved in the pathophysiology of sulfur mustard. This is a first
step for the future approach of epigenetic targets in the treatment of SM-caused
damage. Stable molecular effects and specific targets could be identified to serve as a
basis for further investigations. Ideally they should include in vivo studies with more
gene-specific examinations of DNA and histone modulations. Further they should
comprise therapeutic intervention groups to validate and expand knowledge of the
discovered patterns and the clinical consequences thereof.
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